Pausing a Corporate Venture Programme: A Wind-Down Playbook

Most writing about corporate venture programmes assumes they are moving in one direction: launch, mature, scale. Almost nothing is written about the moment a programme stops, even though pausing one is a routine event. Budgets get reallocated, sponsors change, a parent company restructures. The programme that was fully funded in January can be told to stand down by September, and the team running it usually has no playbook for how to do that without damage.

The absence of guidance is not an accident. A launch is a story a corporate wants to tell. A pause is not. That gap is exactly why it is worth writing down what a disciplined wind-down actually looks like, because the corporates that get it wrong pay for it in reputation, not in the balance sheet line that triggered the decision.

Pausing Is Not the Same Decision as Killing

The first distinction that gets lost in the moment is between a pause and a shutdown. A shutdown ends the mandate, releases the team, and closes the vehicle. A pause stops new deployment while leaving existing commitments and existing relationships intact.

Treating a pause like a shutdown is the single most common mistake, because it triggers behaviour, an abrupt silence toward founders, a scramble to close out relationships, that a genuine shutdown would justify but a pause does not. If the intent is to resume in twelve or eighteen months once budget returns, the programme needs to behave like something on hold, not something ending.

What Happens to the Portfolio Comes First

Before anything is communicated externally, the internal question that has to be settled is what happens to companies already backed. A venture programme that pauses new investment but abandons its existing portfolio companies, no more follow-on support, no more introductions, no more board engagement, has not paused. It has quietly failed the founders who took its money in good faith.

The wind-down sequence should settle three things before any external communication goes out: which existing commitments are contractually binding and must be honoured regardless of the pause, which board seats or observer rights continue and who holds them during the pause, and who inside the corporate remains the point of contact for portfolio companies when the deal team is reduced or reassigned.

The Founders Who Are Mid-Conversation Deserve a Direct Answer

The second group that gets handled badly is not the existing portfolio. It is the founders who were mid-process when the pause hit: a term sheet under negotiation, a first call scheduled, a warm introduction half-made. These are the relationships most exposed to reputational damage, because founders talk to each other, and a corporate that goes silent on a deal in progress is remembered specifically for that silence.

The standard that holds up is simple to state and consistently skipped in practice: every founder in an active conversation gets a direct, personal message within the same week the decision is made, explaining that the programme is pausing new deployment and that the conversation cannot continue on its current timeline. It costs one afternoon of outreach. The alternative, letting these conversations go quiet and hoping nobody notices, is what turns a routine budget decision into a story a founder tells the next three people who ask about the corporate's venture reputation.

What Gets Communicated Externally, and What Does Not

A public announcement is not required for most pauses, and in most cases it should not happen. Overexplaining a pause to the market invites more scrutiny than the decision deserves, because it frames a portfolio management choice as a strategic reversal.

What is required is that everyone with a live relationship, portfolio founders, mid-process founders, the ecosystem partners who send the programme deal flow, hears about the pause directly and hears the same version of it. The version that works is short: the programme is not deploying new capital for a defined or indefinite period, existing commitments are honoured, and a named person remains reachable. Anything longer starts sounding like a justification, and a justification is what invites the follow-up questions a pause is trying to avoid.

The Internal Story Matters as Much as the External One

The corporate's own business units, who may have grown used to the deal flow, the technology scouting, or the co-investment access the programme provided, also need a version of this story, and it needs to be consistent with what founders and portfolio companies were told. A wind-down that tells the market one story and internal stakeholders another creates the exact kind of contradiction that surfaces later, usually when a business unit leader repeats the wrong version to an external partner.

This is also where the credibility of the corporate's leadership is genuinely at stake. A programme that pauses cleanly, honours its commitments, and resumes on schedule reads as disciplined capital allocation. A programme that pauses messily, leaves portfolio companies uncertain, and never quite resumes reads as a corporate that was never serious about venture in the first place, and that reputation attaches to the next attempt, not just this one.

Keeping the Option to Resume Alive

A pause that intends to become a resume needs one thing that is easy to skip when the team is being reassigned: a named owner who tracks the portfolio and the ecosystem relationships during the pause itself, even at reduced capacity. Without an owner, a pause becomes a shutdown by default, not by decision, simply because nobody was responsible for keeping the relationships warm.

The governance and reporting structure built during the first three years of a programme does not need to be dismantled during a pause. It needs to be reduced to whatever a much smaller team can sustain, and written down explicitly so that whoever resumes the programme later is not rebuilding institutional memory from nothing.

What the Mandate Should Have Already Said

Every one of the decisions above is easier when the original mandate or partnership agreement anticipated a pause explicitly, rather than treating continuous operation as the only scenario worth writing into the contract. A mandate that specifies what happens to co-investment rights, board seats, and follow-on commitments if the programme pauses removes the improvisation that causes most of the damage described here. This is the same discipline that should already govern the exit and transition clauses a mandate should already have, applied one stage earlier, to a pause rather than an ending.

Frequently Asked Questions

How is a pause different from simply slowing the pace of investment?

A slowdown still deploys capital, just less of it. A pause stops new deployment entirely for a defined or indefinite period. The distinction matters because a slowdown does not require the same communication discipline a full pause does.

Should the reason for the pause be shared with founders?

A brief, honest reason, budget reallocation, a parent company restructuring, is worth sharing. Vague language invites founders to assume the worst, which is usually a full shutdown, and that assumption spreads faster than a clear explanation would.

What is the biggest risk during a pause?

Losing the relationships that took years to build because nobody was assigned to maintain them. The capital can be redeployed later. A cold relationship with a founder or an ecosystem partner is much harder to rebuild than to keep warm.

Does a paused programme need a public statement?

Rarely. A direct, consistent message to the people with an active relationship almost always serves the programme better than a public one, which tends to invite more scrutiny than the underlying decision warrants.

Conclusion

A corporate venture programme will eventually face a pause, a budget cycle, a restructuring, a change in sponsor, and the programmes that survive it are not the ones that never got paused. They are the ones that paused with a plan: existing commitments honoured, mid-process founders told directly, one story told consistently inside and outside the organisation, and a named owner keeping the relationships warm until deployment resumes. None of that requires much budget. It requires deciding, before the pause happens, that it will be handled this way.

Working on this? Mandalore Partners runs corporate venture programmes for insurers and financial institutions, including the governance work that makes a pause survivable. Talk to us.

Regulatory Pressure on Life Insurance: What It Changes for Product Partnerships

When a corporate insurer and an insurtech discuss a product partnership, the conversation usually centers on distribution: which channel, which customer segment, how fast the integration can ship. It is rarely framed around what a supervisor will want to see about that product before a single customer ever buys it.

That framing is becoming a mistake. Two regulatory developments, one from the European supervisor and one from the French one, are converging on the same target: the value a product actually delivers to the customer who buys it, and the paperwork an insurer must produce to prove it. Neither development is aimed at partnerships specifically. Both change how fast a partnership can move.

The Value for Money Question Is Now a Governance Requirement, Not a Slogan

EIOPA has been explicit about what it found when it looked closely at unit-linked and hybrid life insurance products across the European market: roughly 15% of the products it analysed raised value for money concerns, and more than half of those were marketed by fewer than 20 undertakings. The average projected return across the products reviewed, including higher-risk ones, came out at 2.6%.

EIOPA's own conclusion is worth taking at face value: this is not a structural problem with the European life insurance market. It is a concentrated problem among a minority of providers. That is precisely why it matters to everyone else. A concentrated problem invites a supervisory response calibrated to catch outliers, which means every product, including one built in partnership with a new insurtech entrant, now gets tested against the same bar.

What Product Oversight and Governance Actually Demands

The mechanism EIOPA is using is not new in name. Product Oversight and Governance, POG, has existed under the Insurance Distribution Directive for years. What has changed is how seriously it is enforced. EIOPA's supervisory statement on value for money in unit-linked products sets out three things a national supervisor now checks: that the target market for a product is defined with enough granularity to mean something, that the product has actually been tested for value for money rather than assumed to deliver it, and that costs, charges, and performance are reviewed on an ongoing basis rather than signed off once at launch.

None of that is exotic. All of it takes time, and time is the resource a product partnership is usually trying to save. A partnership that assumed POG documentation could be assembled after commercial terms were agreed is now assuming something that a supervisor is actively testing for.

ACPR Is Not Waiting for Brussels

The European layer is not the only one intensifying. The ACPR's 2026 supervisory programme includes 213 planned missions, up from 185 in 2025. That is a French-specific increase in the volume of hands-on supervisory work, layered on top of the EIOPA-level obligations rather than replacing them.

For a corporate insurer operating primarily in France, this means the compliance conversation about a new product partnership has two audiences with two different rhythms, not one. A mandate or partnership agreement written as though satisfying EIOPA's framework were sufficient is missing half the picture.

Why This Slows Down Partnerships Specifically

An insurer developing a product internally already owns its target market data, its cost structure, and its historical performance record. A partnership introduces a party that owns none of that by default. An insurtech's product economics, however well designed, have to be reconstructed into the insurer's own POG documentation before the insurer can distribute it under its own licence and its own name.

That reconstruction is the invisible cost of a partnership, and it rarely appears in the term sheet. It shows up later, as a delay between signing and launch that neither party budgeted for, and that gets blamed on "compliance" as though compliance were an external event rather than a predictable consequence of the model chosen.

The Governance Cost That Doesn't Show Up in the Term Sheet

This is the same dynamic already visible in how corporates structure venture relationships more broadly: the governance cost of a structure is rarely obvious at the moment a deal is signed, and it is almost always higher than expected once the structure has to run. A distribution partnership that must pass POG testing before launch carries a governance cost that behaves the same way.

The practical answer is not to avoid partnerships. It is to price the governance cost into the timeline from the start, the same discipline that already applies to any external investment or mandate structure, and to write it into the agreement rather than discover it during review.

What This Means for How a Mandate Gets Written

A mandate or partnership agreement negotiated today without an explicit clause on POG review timing is negotiating around a gap that a supervisor will not ignore. The boundaries of the thesis, who can say yes and how fast, and what happens if a product fails value for money testing after launch all need to be settled in writing before the first product goes live, not after the first supervisory question arrives.

Where Corporates Still Move Fast

There is one structure that avoids most of this friction entirely, at least at the pilot stage: the venture client model, where an insurer pays for a pilot without taking equity and without distributing the partner's product under its own licence. Because nothing is sold to an end customer yet, POG obligations do not attach to the pilot itself. That is precisely why this model remains the fastest entry point for testing an insurtech relationship before committing to the governance load of a full distribution partnership.

Frequently Asked Questions

Does this apply only to unit-linked products?

EIOPA's most detailed findings concern unit-linked and hybrid life insurance products specifically. The POG obligations behind them apply more broadly across the Insurance Distribution Directive, but the concentrated evidence of a problem, and the corresponding scrutiny, is strongest on this segment.

Is this a French-specific issue or a European one?

Both, and they stack. EIOPA sets the European framework and the value for money expectation. The ACPR's expanded 2026 programme adds a French-specific layer of supervisory intensity on top of it, not a substitute for it.

Does a venture client pilot avoid this entirely?

It avoids it at the pilot stage, because nothing is distributed to an end customer under the insurer's licence yet. The obligations return in full once the relationship moves from pilot to actual product distribution.

What should a partnership agreement now include because of this?

An explicit allowance for POG review time in the launch timeline, and clarity on which party owns the documentation burden if the product's target market or cost structure changes after launch.

Conclusion

Regulatory pressure on life insurance is not a temporary tightening that will ease once EIOPA's current review cycle ends. The ACPR's own numbers point the other way: more missions in 2026 than in 2025, not fewer. What determines whether a corporate insurer can still move quickly on a product partnership is not whether it can avoid this pressure, but whether it picked a structure, and wrote an agreement, that already accounts for it.

Working on this? Mandalore Partners runs corporate venture programmes for insurers and financial institutions, inclu

What to Measure in Year One of a Corporate Venture Programme

First-year reviews of corporate venture programmes almost always open with the same number: how many deals were done. It is the easiest figure to produce and the easiest to defend in front of a steering committee. It is also the number that carries the least information about whether the programme will still exist in three years. A programme can close eight investments in twelve months and be structurally dead. Another can close two and be in excellent health.

This article sets out what a first-year review should measure instead. Three indicators, none of them a count of transactions, carry more predictive weight than deal volume: how long a decision takes, whether the internal sponsors renew, and where the deals actually came from.

Why Deal Count Fails as a First-Year Metric

Deal count fails for a structural reason, not a philosophical one. In year one, the number of investments a programme closes is mostly a function of how much capital was allocated and how loose the investment criteria were. Both are decisions taken before the programme started. Counting deals therefore measures a budget line and a mandate, not the performance of the team executing them.

It also creates the wrong incentive at the worst possible moment. A team that knows it will be judged on volume at month twelve will lower its bar in month ten. The investments made in that window are the ones most likely to be written off, and they are made precisely when the programme has the least experience to price risk.

There is a second problem. Deal count is not comparable to anything. A corporate that made four investments cannot tell from that number whether it did well, because it has no internal baseline and the external benchmarks compare organisations with different mandates, different capital and different definitions of what counts as a deal.

Decision Cycle Time: The Metric That Predicts Everything Else

The single most informative first-year measurement is the time between first meaningful contact with a company and a documented decision, positive or negative.

It matters for two reasons. The first is competitive: in a contested round, a corporate investor that needs several months to reach a decision is not really in the round. Founders learn this quickly and stop bringing their better opportunities. The programme then experiences a slow degradation of the quality of what it sees, which is invisible in the deal count and fatal to the thesis.

The second reason is diagnostic. Decision cycle time is the only metric that aggregates every structural weakness of a programme into one number. A committee that meets quarterly, an approval chain that runs through a legal department with no venture experience, a mandate ambiguous enough that nobody is sure who can say yes: all of it shows up as elapsed days. When the number is bad, the cause is almost always in the governance design rather than in the team.

Two figures are worth tracking separately: the time to a negative decision, and the time to a positive one. A programme that says no quickly and yes slowly is behaving rationally under an unclear mandate. A programme that says no slowly is wasting the founder's time and its own credibility, and it will be remembered for it.

Sponsor Renewal: Whether the Programme Still Has Internal Buyers

A corporate venture programme is not funded by its returns in year one. It is funded by the continued belief of a small number of executives who agreed to sponsor it. The relevant measurement is therefore whether those sponsors are still actively engaged twelve months in, and whether any new ones have appeared.

This is measurable without ceremony. Which business units requested an introduction to a portfolio company. Which executives attended an investment committee they were not required to attend. Which internal budget holders volunteered a proof of concept. These are observable events, they can be counted, and they are recorded in a calendar rather than in a reporting system.

Sponsor attrition is the most reliable leading indicator of a programme being paused, and it precedes the formal decision by several quarters. A programme that has lost its internal buyers can still be closing deals right up to the week it is suspended, which is exactly why deal count gives no warning.

The counterpart is that a programme with growing internal demand can survive a poor investment year. Corporate venture programmes are rarely shut down for underperformance in a portfolio that is too young to have performance. They are shut down when nobody senior is left to defend them.

Proprietary Sourcing Share: Where the Deals Actually Came From

The third measurement is the share of the pipeline that reached the programme through a channel it built itself, as opposed to through an intermediary who also sent it to everyone else.

The distinction is not about pride of authorship. A pipeline that comes entirely from bankers, accelerator demo days and inbound decks is a pipeline that any competitor can reproduce at the same price, and it will be priced accordingly. A pipeline that comes from a corporate's own operating relationships, from its customers, from its technical teams and from the alumni networks around its sector is the only part of the sourcing function that a competitor cannot buy.

In year one, the absolute share will be low, and that is expected. What the review should look at is the direction of travel across the four quarters, and whether the proprietary channels that exist are maintained by someone whose job it is, or by whoever happened to have time.

This is also the metric most often reported dishonestly, because the definition is elastic. A useful discipline is to define the categories before the year starts, in the mandate agreement and to make the person who sourced the deal name the channel at the moment the company enters the pipeline rather than at the review.

Three Numbers That Look Useful and Are Not

Paper markups. A revaluation in year one reflects the entry price of the next investor, not the judgment of the programme. Reporting it as performance builds an expectation that the same line will keep rising, and it will not.

Portfolio company count. This is deal count with a different label. It answers the same budget question and carries the same incentive problem.

Pipeline volume. The number of companies reviewed measures how much noise reached the team. Without a qualification step, a larger pipeline is a cost, not an asset. If pipeline is tracked at all, it should be tracked as the share that passed a first qualification, and that ratio is more interesting than the total.

What the Year-One Review Should Actually Decide

A first-year review has one useful purpose: deciding whether the programme continues as designed, continues with a changed design, or stops. Framed that way, the three measurements map directly onto the decision.

Decision cycle time tells you whether the governance design works, and it is the one thing that can be fixed quickly without renegotiating anything upstream. Sponsor renewal tells you whether the programme still has a constituency, which determines whether it has a second year at all. Proprietary sourcing share tells you whether the programme is building an asset or renting one, which determines whether the third year is worth funding.

None of these require a reporting function, a data team or a new tool. They require a definition agreed before the year starts, which is a governance question rather than a measurement question, and which belongs in the mandate agreement alongside the fee and approval terms. Programmes that discover in month eleven that they never defined what they were going to measure will spend the review arguing about definitions rather than making a decision.

Frequently Asked Questions

Should returns be measured at all in year one?

They can be recorded, but they should not be used to decide anything. A portfolio built over twelve months has no realised outcomes and its unrealised marks reflect market conditions rather than selection quality.

What is a reasonable decision cycle time for a corporate investor?

There is no defensible universal figure, and any number presented as a standard should be treated with suspicion. The useful comparison is internal: the time the programme took in the fourth quarter against the time it took in the first, and the gap between its negative and positive decisions.

Who should own these measurements?

The programme itself, with the definitions fixed externally. When the team both defines and reports the metric, the definition drifts toward whatever the team is achieving.

Do these metrics apply to an outsourced programme?

They apply more strictly. When a programme runs through an external manager, decision cycle time and sourcing channel are the two variables the corporate is actually paying for, and both should appear in the mandate rather than in a quarterly slide. The cost comparison between the two models rests on the same variables.

Conclusion

Deal count survives as a first-year metric because it is easy to produce and nobody has to defend the definition. The cost of that convenience is that the review measures a budget decision taken a year earlier and learns nothing about whether the programme works.

Decision cycle time, sponsor renewal and proprietary sourcing share are harder to collect, mostly because they require agreement on what they mean before the year begins. What they offer in exchange is a review that can reach a decision: continue, redesign, or stop. A first-year review that cannot reach one of those three conclusions has measured the wrong things.

The First Three Years of a VCaaS Program: A Practical Roadmap

Corporations evaluating a VCaaS mandate can usually find good material on why the model works and how it compares to building internally. What is harder to find is a realistic timeline: what actually happens in year one versus year three, and what milestones indicate a program is on track versus quietly underperforming. This roadmap sets out a practical, stage-by-stage view of how a well-run VCaaS program typically develops over its first three years.

Year One: Mandate, Governance, and First Deals

The first three to six months are almost entirely structural: finalizing the investment thesis, agreeing governance and reporting mechanics, and — if the mandate is structured as a dedicated vehicle rather than direct balance-sheet investment — completing the legal and, where relevant, regulatory setup. Corporations that rush this phase to show early deal activity typically pay for it later with governance disputes or a thesis that needs to be substantially revised within the first year.

From roughly month six, the program should begin closing its first investments — typically three to eight in the remainder of year one, depending on mandate size and stage focus. The realistic goal for year one is not portfolio scale; it is establishing that the sourcing engine works, that the governance model functions at the speed it was designed for, and that the first few investments reflect the thesis accurately. A year-one program that has closed a handful of well-thesis-aligned deals and established a working reporting rhythm is on track, even if the absolute numbers look modest.

Year Two: Portfolio Building and Commercial Activation

Year two is where deal pace typically accelerates, as the sourcing network matures and the governance process proves itself at speed. It is also when the program's strategic value — as opposed to its financial potential, which takes longer to materialize — should start becoming visible, primarily through commercial activation: pilots, distribution conversations, and technical collaboration between portfolio companies and the corporate's business units.

This is the stage where programs most commonly underperform their potential, not because of poor investment selection but because commercial activation was left informal rather than actively managed. A portfolio company with no assigned business-unit sponsor rarely develops a commercial relationship on its own initiative. Programs that treat commercial facilitation as a resourced function — not an occasional bonus — show a measurably higher rate of active portfolio engagement by the end of year two.

Mid-program benchmarking belongs here as well: comparing deal pace, portfolio composition, and early signal quality against the original thesis and against external industry benchmarks, to catch drift before it compounds into year three.

Year Three: Measurable Strategic Value and Strategic Review

By year three, a well-run program should be able to demonstrate a track record on both dimensions of its mandate: early financial signal (follow-on rounds, markups, in some cases early exits) and strategic value (active commercial relationships, technology or market intelligence generated, talent or partnership pipeline). This is also the natural point for a structured strategic review: is the original thesis still the right one, does the program's scale match the corporation's ambition, and should the operating model evolve — scaling the VCaaS mandate, moving toward a hybrid model, or beginning a transition toward a partially internal team.

Programs that treat this review as a formality rather than a genuine strategic decision point tend to drift for another two to three years before the question gets asked seriously — typically triggered by a leadership change rather than a deliberate assessment.

What the Corporate Side Needs to Resource

A VCaaS mandate reduces the corporate's investment execution burden, but it does not eliminate the need for internal resourcing entirely. Across all three years, a corporate should expect to dedicate a senior sponsor with real authority to sit on the investment committee and make timely decisions, and — from year two onward — assigned business-unit contacts for each active commercial relationship, since these do not manage themselves. Corporations that treat the VCaaS mandate as fully turnkey, requiring no internal time investment, are consistently the ones whose commercial activation underperforms in year two.

Milestones to Track at Each Stage

• End of year one — governance and reporting operating as designed, three to eight thesis-aligned investments closed, and a documented, working sourcing pipeline.

• Mid-year two — deal pace at or above the mandate's target run rate, and at least one portfolio company with an active, assigned commercial relationship in progress.

• End of year two — a measurable majority of the portfolio with some form of active commercial engagement, and a mid-program benchmarking review completed against thesis and external data.

• End of year three — demonstrable financial signal, demonstrable strategic value, and a completed strategic review determining the operating model for the next phase.

Common Timeline Mistakes

• Rushing year-one deployment — to show early activity, at the cost of thesis discipline — this is the single most common source of a portfolio that needs significant correction by year two.

• Treating commercial activation as optional — rather than a resourced function, which leaves genuine strategic value underdeveloped even when the investment selection itself is sound.

• Deferring the year-three strategic review — until it is forced by a leadership change or budget pressure, rather than scheduling it as a deliberate part of the program design from the outset.

Frequently Asked Questions

How many investments should a VCaaS program make in its first year?

There is no fixed number, but three to eight investments in the second half of year one is a realistic range for most mandates, with the emphasis on thesis alignment and sourcing quality rather than absolute volume.

When should a corporation expect to see financial returns from a VCaaS program?

Early signals — follow-on rounds and markups — can appear from year two onward, but meaningful realized financial returns from early-stage venture investing typically take five to seven years or more, consistent with venture capital timelines generally.

What triggers a decision to bring a VCaaS program in-house?

Most commonly, sustained deal volume that would justify the fixed cost of an internal team, a long-term strategic commitment that makes deep internal capability building worthwhile, or dissatisfaction with an external partner's alignment or performance — ideally assessed at the year-three strategic review rather than reactively.

Is commercial activation something the VCaaS partner or the corporate is responsible for?

In practice, it works best as a shared responsibility — the VCaaS partner facilitates and manages the relationship, but it requires an assigned sponsor on the corporate's business-unit side to be genuinely productive.

Conclusion

A VCaaS program's first three years follow a reasonably predictable shape: structural setup and first deals in year one, portfolio building and commercial activation in year two, and measurable strategic value alongside a deliberate strategic review in year three. Programs that respect this sequence — rather than trying to compress it to show early results — consistently outperform those that rush it.

Where Insurers Actually Deploy Venture Capital: The Four Models

Most conversations about insurance and startups begin with the wrong question. They ask whether the group should have a venture arm. That question has no useful answer, because there is no single thing called a venture arm. There are four distinct structures, they solve different problems, and they cost very different amounts of governance to run.

An insurer that picks the wrong one does not usually discover the mistake in the portfolio. It discovers it in the friction: a committee that cannot approve anything on a startup's timescale, or a business unit that never adopts what the venture team bought. This article sets out the four models, what each one is actually for, and what each one costs before any capital is deployed.

Model One: The Venture Client, Buying Before Investing

The first model involves no equity at all. The insurer becomes a startup's customer, pays for a pilot, and measures whether the product solves a real internal problem.

The clearest public example in insurance is the Zurich Innovation Championship. Zurich describes the programme, which has run since 2018 and reports more than 150 projects across more than 30 countries, in terms that leave no ambiguity about the mechanism: "Unlike traditional Venture Capital models, we invest in the adoption and validation of a startup's product, service, or technology, without taking equity." The funding it offers is explicitly equity-free.

What this model buys is speed and evidence. A pilot can be authorised by a business unit budget holder rather than an investment committee, and the outcome is a fact about whether the product works inside the organisation rather than a valuation opinion.

What it does not buy is any claim on the upside. If the startup becomes a category leader, the insurer has a supplier relationship and nothing else. That is a deliberate trade, and it is the right one when the strategic question is "does this work for us" rather than "do we want to own part of this".

Model Two: The Dedicated Investment Unit

The second model is the one most people picture: a distinct entity, its own team, its own mandate, investing the group's balance sheet.

Allianz X is a documented example at scale. It presents itself as the strategic investment arm of the Allianz Group and reports 25 current direct investments, more than 1.7 billion in assets under management, five full acquisitions, more than ten exits, and 40 employees across five continents.

Two things are worth noticing in that description. The first is the size of the team relative to the number of positions. A dedicated unit is not a light structure, and the staffing is the real cost, not the capital. The second is that the stated purpose runs beyond returns: the unit exists to build connections between portfolio companies and the group. That is the defining feature of this model, and also its main point of failure. A dedicated unit that produces good returns but no adoption inside the group will eventually be asked what it is for.

Model Three: The External Mandate

The third model delegates the investment function to an external manager operating under a mandate written by the insurer. The insurer keeps the thesis, the strategic direction and usually the co-investment rights. It does not build the team.

This model is deliberately harder to document publicly than the first two, and the honest position is that no insurer mandate can be cited here with a public source. These arrangements are commercial contracts between two private parties, and neither side has an incentive to publicise the terms. Their existence is not in doubt; their details are simply not public.

What can be said structurally is what the mandate has to settle, because that is where the model succeeds or fails: the boundaries of the thesis, who can say yes and how fast, how fees relate to strategic outcomes rather than deployment volume, and what happens at the end of the term. All of that belongs in writing before the first deal, not after the first disagreement, and it is worth reading alongside what the mandate should specify in detail.

The trade in this model is control against speed and cost. The insurer gives up direct authorship of each decision and gains a functioning team without a multi-year hiring cycle. Whether that is a good trade depends almost entirely on how many deals per year the group realistically expects, which is the same variable that drives the cost of each approach.

Model Four: Investing Through Third-Party Funds

The fourth model puts the insurer in the position of investor in someone else's fund, rather than direct investor in companies.

This is the most common and least discussed of the four, because it looks like an allocation decision rather than an innovation decision. It offers diversification, no operational burden, and access to deal flow the insurer would never see alone. It offers almost nothing in strategic proximity: a position in a fund does not give a business unit a reason to talk to a portfolio company, and the reporting arrives quarterly, long after the moment when a commercial conversation would have been useful.

This model is best understood as a complement rather than a competitor to the other three. It is a reasonable way to learn a sector before committing to a structure, and a poor substitute for one.

What Each Model Really Costs in Governance

Capital is rarely the binding constraint for an insurer. Governance is.

The venture client model is the cheapest to govern because the decision sits with whoever owns the budget for the pilot. The dedicated unit is the most expensive, because it requires a permanent team, an investment process, a committee, and a reporting line that has to survive changes in group leadership. The external mandate moves most of that cost outside, but replaces it with the harder task of writing a mandate precise enough to be enforceable. Investing through third-party funds is the lightest of all, and correspondingly the least strategic.

The pattern worth remembering: the more strategic proximity a model offers, the more internal governance it consumes. There is no structure that delivers both close alignment and low overhead.

How to Choose Without Guessing

Three questions settle most of the decision.

What is the real objective? If the group needs to know whether a technology works in its own operations, the venture client model answers that faster and cheaper than any equity structure. If the objective is a claim on the upside of a sector, it does not answer it at all.

How many decisions per year? A group that expects two or three investments a year cannot justify a permanent team, and should be looking at a mandate or at fund positions. A group expecting a genuine flow of transactions can amortise a dedicated unit.

Who inside the organisation will actually adopt the outcome? This is the question most often skipped, and the one that decides whether the programme survives its third year. A model that produces investments nobody internally uses will be defended by its team and by nobody else.

Frequently Asked Questions

Can an insurer run more than one model at once?

Yes, and many do. The combination that works is a venture client programme feeding evidence into an equity structure, so that investment decisions are informed by whether the product actually performed inside the group. The combination that fails is two equity structures with overlapping mandates competing for the same deals.

Is the venture client model just a pilot programme with a new name?

The mechanism is similar. The difference is intent and follow-through: a venture client programme is designed so that a successful pilot leads to a commercial contract, rather than ending in a report.

Does a dedicated unit need to sit outside the insurer legally?

Not necessarily, but it needs to sit outside the insurer operationally. The recurring failure is a unit that reports into a structure whose approval cycle is slower than the market it is investing in.

What is the fastest model to start?

The venture client model, by a wide margin. It requires no vehicle, no committee and no capital allocation, which is also why it is the most common entry point for insurers testing whether they want a venture strategy at all.

Conclusion

The four models are not stages on a maturity path, and an insurer does not graduate from one to the next. They are answers to different questions: whether a technology works, whether to own part of a company, whether to delegate the function, or whether to buy exposure to a sector.

The decision that matters is not which model is best in the abstract. It is which question the group is actually trying to answer this year, and whether it has the governance to support the answer it chooses. Getting that pairing wrong is what produces venture programmes that look active for two years and quietly disappear in the third, a pattern visible in how the first three years of a programme tend to unfold.

Why a Corporate Becomes an LP Instead of Investing Directly

Ask a corporate why it invests directly in startups instead of putting the same capital into venture funds, and the answer is almost always some version of control. Direct investing means picking the companies, sitting closer to the cap table, and keeping the relationship in-house.

What that answer skips is what control costs, and what it buys. Fund investing is not the fallback for corporates without the ambition to build a real programme. For many, it is the structurally correct choice, and understanding why requires separating four things that get treated as one decision: sourcing, selection, governance, and speed.

What Direct Investing Actually Requires

A corporate that invests directly is not just writing checks. It is running a sourcing function that has to compete with funds whose entire business is sourcing, a selection process that has to price risk on assets most corporate teams have never underwritten, and a governance chain that has to move at a pace startups can survive.

None of that is impossible to build. It is expensive to build, and it takes years before it produces a track record good enough to attract the deals that made the exercise worthwhile in the first place. A corporate weighing direct investment against fund investment is really weighing whether it wants to build that capability, not whether it wants exposure to venture-backed companies.

What Becoming an LP Actually Buys

An LP position buys diversification a single corporate could never build alone, a manager whose full-time job is sourcing and pricing, and exposure to a category without carrying the operating cost of a team.

It also buys something less obvious: a faster path to a working relationship with the venture ecosystem. A corporate with no venture programme and no track record is a slow yes for founders and a slow yes for co-investors. A corporate that shows up as an LP in a credible fund inherits some of that fund's standing immediately, which is difficult to buy any other way.

What it does not buy is proximity. An LP sees a quarterly report, not a term sheet in progress. If the strategic objective requires shaping a deal as it happens, this structure will consistently disappoint that objective, no matter how well the fund performs financially.

The Real Trade Is Speed Against Proximity

Every other difference between direct investing and fund investing collapses into this one trade. Direct investing buys proximity: the corporate is at the table when the deal is shaped, and it can attach commercial terms, pilot rights, or board input to the check. Fund investing buys speed: capital can be committed in months rather than the year or more it takes to build a team, a mandate, and a first deal.

Corporates that get this trade wrong tend to make the same mistake in one of two directions. Some commit to direct investing before they have the governance to move at venture speed, and the programme spends its first two years losing good deals to slower internal approval rather than to bad judgement. Others commit to a purely financial LP position when what they actually wanted was commercial access, and then wonder why the fund's portfolio companies never call.

When the Trade Favours a Fund

The case for an LP position is strongest when the corporate's real objective is market intelligence rather than deal-by-deal influence, when the expected deal volume is too low to justify a dedicated team, or when the corporate needs venture exposure now and cannot wait through the multi-year ramp that a direct programme requires before it performs. It is also the more defensible choice when the corporate has no internal capability to evaluate venture-stage risk and would otherwise be pricing deals it does not understand.

When the Trade Favours Direct Investment

The case for direct investment is strongest when the strategic objective cannot be delivered by a passive position: a pilot in a specific business unit, a right of first look in a defined category, or board-level input into how a portfolio company grows. It also tends to favour corporates with enough expected deal volume to make a dedicated capability worth its fixed cost, which is the same variable that drives the cost comparison between the two models.

What Most Corporates Actually Need

Most corporates evaluating this question are not choosing between two pure structures. In practice, an LP position and a direct programme answer different questions, and a corporate can run both at once without contradiction: the fund position for market coverage and manager relationships, a small number of direct positions for the handful of situations where proximity is the actual objective.

What decides whether that combination works is the same discipline that determines whether either structure works alone: a clear statement, in writing, of what each pool of capital is for. A corporate that cannot answer that question before committing capital will not answer it any better after, which is exactly what a mandate agreement is supposed to force before the first commitment is made.

Frequently Asked Questions

Can a corporate become an LP and still get access to deal flow?

Some fund structures include co-investment rights for LPs, which partially closes the proximity gap. That right has to be negotiated explicitly; it is not a standard feature of a fund commitment.

Is fund investing cheaper than direct investing?

Usually, once the internal team, governance and multi-year ramp-up of a direct programme are counted. The comparison is detailed in the cost comparison between the two models.

Does becoming an LP first make a later direct programme easier?

Often, because it establishes a track record and a set of relationships that a first-time direct investor has to build from nothing. This is a common path in the first three years of a programme.

What is the most common mistake corporates make in this decision?

Choosing based on which option feels more strategic rather than on how many decisions the corporate actually expects to make per year. A structure built for volume that never arrives, or a passive position when the objective required proximity, both fail for the same reason: the structure did not match the actual number of decisions the corporate needed to make.

Conclusion

Direct investing and fund investing are not a beginner's option and an advanced one. They are answers to different strategic questions, and the corporates that get this decision wrong are usually the ones that never asked which question they were actually answering.

The choice is not between ambition and caution. It is between proximity and speed, and between a capability worth building and one worth renting. Getting that pairing right, before any capital moves, is what determines whether the structure still makes sense in year three.

The First Three Years of a VCaaS Program: A Practical Roadmap

Corporations evaluating a VCaaS mandate can usually find good material on why the model works and how it compares to building internally. What is harder to find is a realistic timeline: what actually happens in year one versus year three, and what milestones indicate a program is on track versus quietly underperforming. This roadmap sets out a practical, stage-by-stage view of how a well-run VCaaS program typically develops over its first three years.

Year One: Mandate, Governance, and First Deals

The first three to six months are almost entirely structural: finalizing the investment thesis, agreeing governance and reporting mechanics, and — if the mandate is structured as a dedicated vehicle rather than direct balance-sheet investment — completing the legal and, where relevant, regulatory setup. Corporations that rush this phase to show early deal activity typically pay for it later with governance disputes or a thesis that needs to be substantially revised within the first year.

From roughly month six, the program should begin closing its first investments — typically three to eight in the remainder of year one, depending on mandate size and stage focus. The realistic goal for year one is not portfolio scale; it is establishing that the sourcing engine works, that the governance model functions at the speed it was designed for, and that the first few investments reflect the thesis accurately. A year-one program that has closed a handful of well-thesis-aligned deals and established a working reporting rhythm is on track, even if the absolute numbers look modest.

Year Two: Portfolio Building and Commercial Activation

Year two is where deal pace typically accelerates, as the sourcing network matures and the governance process proves itself at speed. It is also when the program's strategic value — as opposed to its financial potential, which takes longer to materialize — should start becoming visible, primarily through commercial activation: pilots, distribution conversations, and technical collaboration between portfolio companies and the corporate's business units.

This is the stage where programs most commonly underperform their potential, not because of poor investment selection but because commercial activation was left informal rather than actively managed. A portfolio company with no assigned business-unit sponsor rarely develops a commercial relationship on its own initiative. Programs that treat commercial facilitation as a resourced function — not an occasional bonus — show a measurably higher rate of active portfolio engagement by the end of year two.

Mid-program benchmarking belongs here as well: comparing deal pace, portfolio composition, and early signal quality against the original thesis and against external industry benchmarks, to catch drift before it compounds into year three.

Year Three: Measurable Strategic Value and Strategic Review

By year three, a well-run program should be able to demonstrate a track record on both dimensions of its mandate: early financial signal (follow-on rounds, markups, in some cases early exits) and strategic value (active commercial relationships, technology or market intelligence generated, talent or partnership pipeline). This is also the natural point for a structured strategic review: is the original thesis still the right one, does the program's scale match the corporation's ambition, and should the operating model evolve — scaling the VCaaS mandate, moving toward a hybrid model, or beginning a transition toward a partially internal team.

Programs that treat this review as a formality rather than a genuine strategic decision point tend to drift for another two to three years before the question gets asked seriously — typically triggered by a leadership change rather than a deliberate assessment.

What the Corporate Side Needs to Resource

A VCaaS mandate reduces the corporate's investment execution burden, but it does not eliminate the need for internal resourcing entirely. Across all three years, a corporate should expect to dedicate a senior sponsor with real authority to sit on the investment committee and make timely decisions, and — from year two onward — assigned business-unit contacts for each active commercial relationship, since these do not manage themselves. Corporations that treat the VCaaS mandate as fully turnkey, requiring no internal time investment, are consistently the ones whose commercial activation underperforms in year two.

Milestones to Track at Each Stage

• End of year one — governance and reporting operating as designed, three to eight thesis-aligned investments closed, and a documented, working sourcing pipeline.

• Mid-year two — deal pace at or above the mandate's target run rate, and at least one portfolio company with an active, assigned commercial relationship in progress.

• End of year two — a measurable majority of the portfolio with some form of active commercial engagement, and a mid-program benchmarking review completed against thesis and external data.

• End of year three — demonstrable financial signal, demonstrable strategic value, and a completed strategic review determining the operating model for the next phase.

Common Timeline Mistakes

• Rushing year-one deployment — to show early activity, at the cost of thesis discipline — this is the single most common source of a portfolio that needs significant correction by year two.

• Treating commercial activation as optional — rather than a resourced function, which leaves genuine strategic value underdeveloped even when the investment selection itself is sound.

• Deferring the year-three strategic review — until it is forced by a leadership change or budget pressure, rather than scheduling it as a deliberate part of the program design from the outset.

Frequently Asked Questions

How many investments should a VCaaS program make in its first year?

There is no fixed number, but three to eight investments in the second half of year one is a realistic range for most mandates, with the emphasis on thesis alignment and sourcing quality rather than absolute volume.

When should a corporation expect to see financial returns from a VCaaS program?

Early signals — follow-on rounds and markups — can appear from year two onward, but meaningful realized financial returns from early-stage venture investing typically take five to seven years or more, consistent with venture capital timelines generally.

What triggers a decision to bring a VCaaS program in-house?

Most commonly, sustained deal volume that would justify the fixed cost of an internal team, a long-term strategic commitment that makes deep internal capability building worthwhile, or dissatisfaction with an external partner's alignment or performance — ideally assessed at the year-three strategic review rather than reactively.

Is commercial activation something the VCaaS partner or the corporate is responsible for?

In practice, it works best as a shared responsibility — the VCaaS partner facilitates and manages the relationship, but it requires an assigned sponsor on the corporate's business-unit side to be genuinely productive.

Conclusion

A VCaaS program's first three years follow a reasonably predictable shape: structural setup and first deals in year one, portfolio building and commercial activation in year two, and measurable strategic value alongside a deliberate strategic review in year three. Programs that respect this sequence — rather than trying to compress it to show early results — consistently outperform those that rush it.

What to Negotiate in a VCaaS Mandate Agreement: A Practical Checklist

A VCaaS relationship is only as good as the mandate agreement that defines it. The concepts that make the model work in theory — aligned incentives, clear governance, defined strategic value — either get written into enforceable contract terms or they get renegotiated deal by deal, which is where most disappointing VCaaS relationships actually go wrong. This is a practical checklist of what to negotiate before signing, organized by the areas that most consistently determine whether a mandate performs.

Investment Thesis and Mandate Scope

The mandate should define sectors, geographies, stage focus and the balance between financial and strategic objectives in specific, testable terms — not aspirational language. "Fintech and adjacent technology" is not a thesis; "Series A-B European payments and embedded finance infrastructure, with a strategic priority on companies with distribution synergy to our commercial banking business" is. Equally important is defining how and how often the thesis can be revised, since market conditions and corporate strategy both shift over a multi-year mandate.

Exclusivity terms deserve specific attention: does the VCaaS partner work exclusively for this corporate in the defined sector, or do they run parallel mandates for other clients — potentially including competitors? Neither answer is automatically wrong, but it should be explicit and priced accordingly. A related, frequently overlooked point is what happens to deal flow the manager sources that falls just outside the defined thesis: a good mandate specifies whether these are shared as informational flow, offered on a right-of-first-refusal basis, or simply passed to the manager's other relationships.

Governance and Approval Rights

The mandate should specify the composition and authority of the investment committee, the threshold above which the corporate must approve individual investments (versus deals the manager can execute independently within the mandate), and the reporting cadence and format. The single most common governance failure is a mandate that is vague enough to allow slow, ad hoc approval processes to develop in practice — even when the contract nominally promises venture-speed decision-making.

Decision-making timelines are worth stating as explicit service levels: for example, a defined number of business days for the corporate to respond to an investment recommendation, after which the manager may proceed or the opportunity is deemed declined. Without this, informal delay becomes the default.

Fee and Economics Terms

Whether the mandate follows management-fee-plus-carry economics, a flat retainer, or a deal-based structure, the fee base should be unambiguous — committed capital, deployed capital, and net asset value produce materially different fee outcomes over the life of a mandate, and the difference should be modeled before signing, not discovered afterward. If carried interest applies, the hurdle rate, the calculation methodology, and whether carry is calculated per-deal or on the portfolio as a whole should all be explicit.

Alignment mechanisms are worth negotiating directly: does the manager co-invest its own capital alongside the corporate, and does fee income step down if performance falls below an agreed threshold? Mandates with genuine alignment mechanisms consistently outperform those relying on trust alone.

Co-Investment and Information Rights

A well-structured mandate gives the corporate explicit co-investment rights — the ability to invest directly, alongside the fund, in specific companies of particular strategic interest — and defines the process and timeline for exercising them. Information rights should cover not just standard financial reporting but visibility into the full pipeline the manager is evaluating, not only the deals ultimately recommended, since pipeline visibility is often where the most valuable strategic intelligence sits.

Commercial Facilitation Clauses

If part of the strategic case for the mandate is facilitating commercial relationships between portfolio companies and the corporate's business units — pilots, distribution agreements, data-sharing arrangements — the mandate should define who is responsible for introducing and managing those relationships, and clarify data, IP and confidentiality boundaries between the portfolio company, the manager, and the corporate's operating businesses. Ambiguity here is a common source of friction later, particularly around what information the corporate's business units can access about a portfolio company versus what remains confidential to the investment relationship.

Exit, Term, and Transition Provisions

Mandate term length, renewal conditions, and — critically — transition provisions if the corporate later wants to bring the function in-house or switch providers, should be agreed at signing rather than negotiated under pressure later. A well-drafted mandate specifies how portfolio positions, board seats, and ongoing relationships transfer in a transition scenario, and over what notice period. Corporates that skip this clause often find that switching providers is far more disruptive than it needed to be.

Red Flags to Watch For

Vague thesis language — that would allow the manager to justify almost any investment as being within scope.

• No defined decision-making service level — leaving informal delay as the default approval process.

• No alignment mechanism — beyond a flat fee, with no co-investment or performance-linked economics from the manager.

• Silence on transition mechanics — leaving portfolio transfer and continuity undefined until the corporate actually wants to exit or restructure the relationship.

How to Run the Negotiation Itself

The most productive mandate negotiations involve the corporate's legal, finance and business-sponsor stakeholders from the outset, rather than treating the agreement as a legal-only exercise finalized after the business terms are agreed informally. Governance and commercial facilitation terms in particular need input from the business units that will actually receive portfolio company introductions — legal counsel alone is rarely positioned to specify what a workable commercial facilitation process looks like in practice.

It is also worth requesting reference conversations with the manager's other corporate mandates, specifically about how disputes or ambiguous mandate scope questions were resolved in practice — not just about investment performance. How a manager handles the inevitable gray areas is a better predictor of relationship quality than the contract language alone.

Frequently Asked Questions

How specific should the investment thesis be in a VCaaS mandate?

Specific enough to be testable against an actual deal: sector, stage, geography, and the relative weight of financial versus strategic objectives, with a defined process for revising it over the life of the mandate.

What decision-making timeline should a corporate expect to negotiate?

There is no universal standard, but mandates that specify an explicit number of business days for corporate response to investment recommendations consistently avoid the informal delay that undermines venture-speed decision-making.

Should a VCaaS manager be required to co-invest its own capital?

It is not mandatory, but mandates with a genuine alignment mechanism — manager co-investment, performance-linked fee adjustments, or both — are generally associated with stronger long-term performance than fee-only structures.

What happens to portfolio companies if a corporate ends a VCaaS mandate?

This should be defined explicitly in the mandate's transition provisions. Without pre-agreed terms, portfolio transfer, board seat continuity, and ongoing relationship management can become a significant source of disruption during a transition.

Conclusion

The difference between a VCaaS relationship that performs and one that disappoints is rarely the underlying concept — it is almost always the specificity of the mandate agreement. Thesis scope, governance service levels, fee alignment, co-investment rights, commercial facilitation boundaries, and transition provisions are the six areas worth spending real negotiating time on before signing.

How Much Does VCaaS Actually Cost? Comparing Venture Capital as a Service to an Internal CVC Team

The decision between building an internal corporate venture team and partnering with a Venture Capital as a Service (VCaaS) provider is usually framed around governance, speed and talent access. It is rarely framed around cost — even though the economics are often the deciding factor once a corporation gets past the strategic case. This article sets out a practical framework for comparing what VCaaS actually costs against the true, fully-loaded cost of building an internal corporate venture capital team.

How VCaaS Providers Typically Charge

VCaaS pricing generally follows one of, or a blend of, three models. The most common mirrors standard venture fund economics: a management fee, typically in the range of 1% to 2.5% of committed or deployed capital annually, covering sourcing, diligence and portfolio management, plus a carried interest share of investment gains — often 15% to 20%, frequently with a hurdle rate that must be cleared before the carry applies. Some providers instead charge a flat retainer for advisory and sourcing services, with deal-by-deal fees for execution. A smaller number charge purely on a deal basis, with no ongoing retainer, which tends to suit corporates that want occasional access rather than a continuous program.

The right structure depends heavily on mandate intensity: a corporate expecting a steady cadence of investments over several years is usually better served by the management-fee-plus-carry model, which aligns the provider's incentives with sustained portfolio performance rather than one-off transactions. A corporate testing the model with a handful of opportunistic deals before committing to a full program is often better served by a deal-based or retainer structure, which avoids paying for capacity that a low, uncertain deal pace will not use.

It is also worth distinguishing management fee base carefully: a fee calculated on committed capital is predictable but can feel expensive in years with low deployment, while a fee calculated on deployed or invested capital scales more naturally with actual activity but is less predictable for budgeting purposes. Neither is inherently better — but the two produce materially different cost profiles over a multi-year mandate, and the difference is worth modeling explicitly before signing rather than discovering later.

The True Cost of Building an Internal CVC Team

The headline cost of an internal team is compensation: a credible corporate venture function typically requires, at minimum, a head of venture with prior institutional VC or CVC experience, one to two investment professionals, and part-time or fractional support from legal, compliance and portfolio operations. Experienced venture investors command venture-market compensation, which is frequently well above standard corporate pay bands for equivalent seniority — a recurring source of both cost and retention difficulty.

The larger, less visible cost is time. Building proprietary deal flow, co-investor relationships and sector pattern recognition from a standing start takes most internal teams several years, during which the program pays full run-rate costs while generating a fraction of the deal quality and pace a mature program would achieve. This ramp-up period is the single largest hidden cost of the build-internally path, and it rarely appears in the initial budget case presented to leadership.

A Side-by-Side Cost Framework

Cost profile — an internal team is largely fixed cost — salaries and overhead are payable regardless of deal pace — while VCaaS fees scale with committed capital and, through carry, with actual performance.

• Time to first deal — a VCaaS partner with existing deal flow can typically close a first investment within months of a finalized mandate; an internal team usually needs a year or more to build a credible pipeline from scratch.

• Cost at low deal volume — for programs targeting fewer than five to eight investments a year, the fixed cost of an internal team is rarely justified by the fee economics of an equivalent VCaaS mandate.

• Cost at high, sustained deal volume — for large, long-horizon programs with double-digit annual deal counts, the cumulative management fee and carry on a VCaaS mandate can, over many years, approach or exceed what a mature internal team would have cost — though it arrives without the multi-year ramp-up risk.

Hidden Costs on Both Sides

Internal programs carry hidden costs beyond compensation: recruiting fees and severance risk in a function with historically high turnover, technology and data tooling that a mature external partner has already amortized across many clients, and the compliance and fund administration infrastructure required if the program is structured as a dedicated vehicle rather than balance-sheet investment.

VCaaS mandates carry their own less visible costs: the corporate typically has less day-to-day control over brand and messaging in portfolio company relationships, reporting is only as good as the infrastructure the provider has built, and switching providers — while possible — involves transition costs of its own, including the risk of losing continuity with existing portfolio companies.

When the Economics Favor Each Model

As a general pattern, VCaaS tends to offer superior unit economics for programs below roughly €20 to €50 million in committed capital, for corporations without existing venture investing expertise, and for programs that need to demonstrate results within the first one to two years. Building internally tends to be justified at larger scale, for corporations with a genuine multi-decade strategic commitment to venture investing as a core capability, or where deep proprietary integration with internal R&D and business units outweighs the cost premium of the ramp-up period.

Many mature programs ultimately land on a hybrid: starting with a VCaaS mandate to establish track record and organizational buy-in, then evaluating a transition to a partially or fully internal model once deal volume and strategic value are proven — a path that a well-structured mandate agreement should explicitly accommodate rather than treat as an afterthought.

Modeling the Break-Even Point

Rather than comparing a fee percentage to a salary line, the more useful exercise is modeling total cost over a realistic multi-year horizon under each model, at the deal volume the strategic thesis actually requires. An internal team's cost curve is front-loaded and roughly flat — full run-rate cost from year one, largely independent of how many deals actually close during the ramp-up period. A VCaaS mandate's cost curve tracks capital deployed and, through carry, actual performance — lower absolute cost in early years when deployment is naturally slower, scaling up only as the program demonstrates activity and results.

Plotted over a five-year horizon, these two curves typically cross at a specific, calculable point that depends on target deal volume, average check size, and expected performance. Corporations that model this explicitly — rather than relying on a general sense that "building internally is more expensive" or "VCaaS fees add up over time" — make a substantially more defensible case to their own finance and leadership stakeholders, and are better positioned to negotiate mandate terms that reflect their actual expected usage rather than a generic fee template.

Frequently Asked Questions

Is VCaaS cheaper than building an internal CVC team?

Usually, in the first several years and for programs below roughly €20-50 million in committed capital, because it avoids the multi-year ramp-up cost of building proprietary deal flow from scratch. At very large scale and over long horizons, the fee and carry economics can eventually approach the cost of a mature internal team, though without the ramp-up risk.

What is a typical management fee for a VCaaS mandate?

Most mandates that follow standard venture fund economics charge in the range of 1% to 2.5% of committed or deployed capital annually, though flat retainer and deal-based structures also exist and suit different mandate intensities.

Does carried interest apply to VCaaS mandates?

Where the mandate follows fund-style economics, yes — typically 15% to 20% of investment gains, often subject to a hurdle rate. Retainer-based and deal-fee structures may not include carry at all, generally in exchange for a higher fixed fee.

Can a corporation switch from VCaaS to an internal team later?

Yes, and it is a common trajectory — but the mandate agreement should specify the transition mechanics (portfolio transfer, continuity of relationships, notice periods) up front, rather than being negotiated for the first time when the corporate wants to make the change.

Conclusion

The cost comparison between VCaaS and an internal CVC team is rarely as simple as comparing a fee percentage to a headcount budget. The fixed-cost, multi-year ramp-up profile of an internal team and the variable, performance-linked profile of a VCaaS mandate serve different strategic situations well — and the right answer depends more on expected deal volume, time horizon and existing internal expertise than on which number looks smaller in the first-year budget.

What Makes a Co-Investment Structure Credible to Professional Investors

Too many co-investment structures look good on paper but fall short when scrutiny hits. You want to know which elements truly matter to professional investors before committing capital. We outline the clear markers that make a co-investment SPV credible, focusing on governance and alignment, minority protections, and disciplined execution. For more insights, you might find this resource helpful.

Key Elements of Credible Co-Investment Structures

Governance and Alignment

Proper governance is the foundation of any credible co-investment structure. It ensures that all parties involved have a clear understanding of their roles and responsibilities. Investors look for structures where decision-making processes are well-defined and transparent. This clarity helps in building trust and confidence among stakeholders.

Governance is not just about rules; it's about creating an environment where everyone knows their place. Alignment, on the other hand, ensures that all parties have their interests aligned towards a common goal. This means that the success of the investment benefits everyone involved, not just a select few. To delve deeper into this topic, consider reading this insight.

Minority Protections and Allocation Policy

Minority protections are crucial in safeguarding the interests of smaller investors. These protections ensure that minority stakeholders are not sidelined in decision-making processes. Allocation policies should be fair and transparent, ensuring that all investors have an equal opportunity to participate in investment decisions.

Having a clear and fair allocation policy is essential. It prevents conflicts and ensures that every investor, regardless of size, has a voice. Professional investors often scrutinize these policies to ensure they are not at a disadvantage. For more on this, check out this white paper.

Transparent Fees and Carry

Understanding how fees and carry are structured is vital. Transparent fee structures ensure that investors know exactly what they are paying and what they are getting in return. This clarity helps in building trust and confidence among investors.

A well-structured fee model is not just about transparency; it's about fairness. Investors should know how fees are calculated and what they cover. This knowledge helps them make informed decisions and ensures they are not blindsided by unexpected costs.

Rigorous Investment Processes

Valuation and Conflict of Interest Policies

Rigorous investment processes are crucial for maintaining credibility. Valuation policies should be clear and consistent to ensure fairness. Conflict of interest policies must be in place to prevent any potential biases or unfair advantages.

Investors need assurance that valuations are conducted objectively and without bias. Clear conflict of interest policies ensure that all parties are treated fairly. This transparency helps in building trust and confidence among investors.

Investment Committee Process and Reporting

An effective investment committee process is essential for ensuring that all investment decisions are made systematically. Regular reporting keeps all stakeholders informed and involved in the decision-making process.

The investment committee must be transparent and inclusive. Regular updates and reports keep stakeholders informed and engaged. This involvement is crucial for maintaining trust and ensuring that all parties are aligned in their goals.

Deal Selection Discipline and Downside Protection

Deal selection discipline ensures that only the most promising investments are pursued. Downside protection strategies are essential for mitigating risks and safeguarding investments.

A disciplined approach to deal selection is crucial for ensuring that investments are sound. Downside protection strategies help mitigate risks and protect investments. Investors value these strategies for their ability to safeguard their interests.

Delivering Post-Close Value

Board-Level Engagement

Active engagement at the board level is crucial for ensuring that all stakeholders are aligned and informed. Regular meetings and updates keep everyone on the same page and involved in the decision-making process.

Board-level engagement ensures that all stakeholders are aligned and informed. Regular meetings and updates keep everyone involved and engaged in the decision-making process. This involvement is crucial for maintaining trust and ensuring that all parties are aligned in their goals.

Portfolio Acceleration Services and Impact KPIs

Portfolio acceleration services are essential for ensuring that investments reach their full potential. Impact KPIs provide clear metrics for measuring success and ensuring that all parties are aligned in their goals.

Acceleration services provide the support needed to maximize investment potential. Impact KPIs offer measurable metrics for success, ensuring that everyone is aligned in their objectives. These tools are invaluable for maintaining trust and ensuring that all parties are working toward a common goal.

Frequently Asked Questions

What are the key elements of a credible co-investment structure?
A credible co-investment structure includes strong governance, minority protections, transparent fees, and rigorous investment processes. These elements build trust and ensure alignment among all parties involved.

Why are transparent fees and carry important in co-investments?
Transparent fees and carry provide clarity for investors, ensuring they understand costs and returns. This transparency builds trust and helps investors make informed decisions.

How do minority protections safeguard investors?
Minority protections ensure smaller investors have a voice in decision-making. Fair allocation policies prevent sidelining and ensure equal opportunities for all stakeholders.

Venture Building vs Venture Capital: A Decision Framework for Founders and Corporates

Many founders and corporate leaders face a tough choice: build ventures from the ground up or back startups through venture capital. Each path offers distinct trade-offs that shape control, speed, and risk. This post breaks down the core differences between venture building and venture capital, then offers a clear decision framework tailored to your goals, whether you lead a fintech startup, an insurtech venture studio, or a corporate innovation team. Understanding these options sharpens your innovation strategy and founder–investor alignment. For more information, visit this guide on choosing the right approach to venture building.

Understanding Venture Building

Venture building offers an alternative to traditional funding models by focusing on the creation and growth of startups from the ground up. Here's how it works and when it shines.

Definition and Key Characteristics

Venture building involves creating new companies with a hands-on approach. These organizations, often known as venture studios, provide resources, expertise, and operational support. Unlike traditional investors, venture builders actively manage startups, helping founders with critical decisions and strategy implementation.

A key characteristic is the shared infrastructure that venture builders offer. This includes access to experienced teams, office space, and technology platforms. The goal is to accelerate growth by providing startups with the tools they need to succeed. Venture builders often take a larger equity stake in these companies, reflecting their deep involvement in day-to-day operations.

Advantages and Challenges

Venture building comes with distinct benefits and hurdles. A significant advantage is the comprehensive support provided to startups. Founders benefit from expert guidance, reducing the risk of failure. This model also allows startups to iterate quickly, as they have access to immediate feedback and resources.

However, the challenges are notable. The venture builder's deep involvement can lead to less autonomy for founders. There's also a high dependency on the venture studio's resources and networks. If these are limited, the startup's growth may be stunted. Founders need to weigh the trade-offs between gaining strategic support and retaining control over their company.

Ideal Use Cases and Scenarios

Venture building suits specific scenarios. It's an excellent fit for sectors like fintech and insurtech, where rapid iteration and regulatory navigation are essential. Startups that benefit from a collaborative environment and shared resources thrive under this model. It's also ideal for founders looking for strategic partners who offer more than just capital. If your goal is to rapidly develop a product with expert guidance, venture building might be the best path forward.

Exploring Venture Capital

Venture capital offers a different route, focusing on financial investment rather than operational involvement. Let's explore how this model functions and when it fits best.

Core Principles and Structure

Venture capital (VC) involves investing in startups in exchange for equity. VCs provide the financial resources needed to scale a business, aiming for significant returns when the company succeeds. This model typically involves less operational involvement compared to venture building.

The structure of a VC firm includes partners who manage the fund and make investment decisions. They often focus on specific industries or stages of business development. The primary goal is to identify high-growth potential companies and support them financially through multiple funding rounds. Learn more about the principles of venture capital.

Benefits and Drawbacks

Venture capital offers substantial benefits, such as access to large amounts of funding that can drive rapid expansion. This model can significantly increase a startup's market presence and valuation. VCs also bring valuable networks of contacts that can open doors for partnerships and additional funding.

However, there are drawbacks. The pressure to deliver quick returns can lead to aggressive growth strategies that may not align with the founder's vision. Additionally, founders might face dilution of ownership and decision-making power. Venture capital works best when the potential for rapid scaling outweighs the need for control and when the market opportunity is significant enough to justify the investment.

Suitable Applications and Contexts

Venture capital is well-suited for startups in high-growth industries like technology and biotechnology, where financial resources can catalyze significant advancements. It's ideal when a business has a scalable model and requires large capital injections to capture market share swiftly. For founders ready to trade some control for rapid growth and who have a clear path to a large market, venture capital can be the right fit. Explore the differences between private equity and venture capital.

Decision Framework for Founders

Choosing between venture building and venture capital involves careful consideration of your business goals and resources. This framework helps guide your decision.

Factors to Consider

When evaluating your options, consider your startup's needs, your desire for control, and your growth objectives. If you value strategic guidance and are in a sector that benefits from shared resources, venture building might be more suitable. On the other hand, if you need significant capital to scale quickly and can handle external pressures, venture capital could be more advantageous.

Assess your readiness to collaborate deeply with partners. Venture building requires openness to external input and a willingness to leverage shared resources. Venture capital demands a focus on rapid growth and scalability, often at the expense of autonomy.

Hybrid Models and Combinations

Some founders find success by combining elements of both models. A hybrid approach allows you to leverage the strengths of venture building's strategic support and venture capital's financial power. This combination can be particularly effective in industries like fintech, where both expertise and funding are critical for success.

By blending these models, you might take initial support from a venture builder to develop the product, then seek venture capital to scale rapidly. This approach requires careful alignment of goals with your partners to ensure that both strategic support and financial backing are optimized.

Strategic Alignment and Outcomes

Ultimately, your choice should align with your long-term vision and the outcomes you value. Consider how each model supports your innovation strategy and founder–investor alignment. With the right model, you can achieve the growth and impact you envision for your startup, whether through the strategic capital from venture building or the financial strength of venture capital. For more insights, read this article on corporate venture builders.

Frequently Asked Questions

What is the main difference between venture building and venture capital?

Venture building involves a hands-on approach to creating startups, offering resources and strategic support, while venture capital focuses on providing financial investment for equity, with less operational involvement.

When should a startup choose venture building over venture capital?

A startup should consider venture building if it benefits from shared resources, strategic guidance, and operates in sectors like fintech or insurtech, where rapid iteration is crucial.

Can a startup use both venture building and venture capital?

Yes, a hybrid approach can be effective, leveraging the strategic support of venture building initially, followed by the financial power of venture capital for scaling.

What are the challenges of using venture building?

Challenges include potential loss of autonomy for founders and a high dependency on the venture studio's resources. The model requires alignment with the venture builder's goals.

What sectors are ideal for venture capital investment?

Sectors like technology and biotechnology, which require significant capital for rapid growth and have large market opportunities, are ideal for venture capital investment.

FinTech Radar 2026 : les innovations financières que les investisseurs et CVC doivent réellement suivre

Le FinTech Radar 2026 montre une bascule nette : dans les services financiers, l’enjeu n’est plus d’identifier les innovations à la mode, mais de décider lesquelles méritent un vrai déploiement, lesquelles relèvent encore de l’expérimentation, et lesquelles doivent être mises en attente. Pour un investisseur, un corporate venture capital ou une direction innovation, ce changement de lecture est décisif : la valeur se crée moins dans le buzz technologique que dans la capacité à arbitrer le bon timing, la bonne architecture et le bon niveau de risque.

Pourquoi le FinTech Radar 2026 mérite l’attention des investisseurs

Le rapport s’appuie sur une base concrète : 83 FinTech interrogées, des retours de CTO et de VP Engineering, et une grille simple mais robuste de priorisation en quatre niveaux - Adopt, Trial, Assess, Hold. Cette méthode est utile car elle sort d’une logique purement éditoriale. Elle permet de distinguer les thèmes réellement industrialisés de ceux qui restent séduisants sur le papier mais encore fragiles en exécution.

Le signal principal du radar est clair : la FinTech entre dans une phase d’industrialisation technologique. L’IA générative et l’agentique ne sont plus des gadgets de productivité. Elles touchent désormais la fabrication logicielle, la qualité de la donnée, la lutte contre la fraude, les workflows métier, la conformité et, à terme, la structure même du coût marginal dans les services financiers.

Pour un CVC, le point essentiel est le suivant : les gagnants des trois prochaines années ne seront pas seulement les acteurs qui utilisent l’IA, mais ceux qui l’intègrent dans une stack cohérente, gouvernée et conforme. Autrement dit, le moat ne sera pas le modèle lui-même. Le moat sera le couple données + exécution + conformité.

Les quatre paris structurants du FinTech Radar 2026

Premier pari : l’expérience utilisateur devient une infrastructure de conversion et de conformité. Dans le quadrant User Experience & Interface, le radar place en Adopt le prototypage par l’IA, les design systems, les universal apps et les orchestrateurs KYC. C’est un message fort. Le front n’est plus une simple couche cosmétique ; il devient un moteur de vitesse produit, de cohérence opérationnelle et de réduction de friction réglementaire. Pour un investisseur, cela signifie qu’une bonne UX dans la finance n’est plus un nice-to-have : c’est un levier direct de CAC, d’activation et de conversion.

Deuxième pari : la donnée et l’IA sont déjà au cœur du modèle opérationnel. Le quadrant Data & AI confirme que plusieurs briques sont sorties de la phase d’exploration. L’autonomisation par l’IA, le data quality & fraud monitoring, le développement agentique, les agents asynchrones de développement et le retrieval-augmented generation sont classés en Adopt. En revanche, les workflows agentiques avancés, les données synthétiques, le Model Context Protocol et les architectures multi-agents restent en Trial. Le message est nuancé mais très utile : l’IA de production existe déjà, mais l’agentique complexe demande encore de la discipline, des garde-fous et des cas d’usage circonscrits.

Troisième pari : les couches platform et core sont en recomposition. L’agrégation Open Banking, les plateformes de Banking-as-a-Service, les portails développeurs et l’architecture événementielle sont considérés comme suffisamment mûrs pour être adoptés. En revanche, la tokenisation, l’Open Finance et l’initiation de paiement restent davantage en Assess, tandis que la RPA est reléguée en Hold. Dit autrement, le marché récompense les stacks ouvertes, temps réel et API-driven, mais reste plus prudent sur les promesses trop narratives quand les standards, l’adoption ou l’économie unitaire ne sont pas encore stabilisés.

Quatrième pari : la confiance devient une infrastructure de croissance. Le quadrant Trust & Security pousse en Adopt les passkeys, le compliance as code, la conformité continue et les scanners de vulnérabilités. C’est probablement l’un des enseignements les plus sous-estimés du rapport. Dans la finance, la conformité cesse d’être un coût de back-office. Elle devient un accélérateur de déploiement, un facteur de crédibilité commerciale et, dans certains cas, une véritable barrière à l’entrée.

Ce que le radar dit vraiment sur la création de valeur en FinTech

Le rapport pointe un déplacement très net de la valeur. L’accès aux modèles d’IA est en voie de commoditisation. En revanche, la qualité des données, la structuration des workflows, la sécurité des accès et la capacité à industrialiser les opérations deviennent des actifs rares. C’est une grille d’analyse puissante pour l’investissement : si une startup prétend être “AI-native” mais ne possède ni accès privilégié à la donnée, ni boucle d’apprentissage métier, ni intégration profonde dans le workflow client, son avantage défendable risque d’être faible.

La deuxième source de création de valeur identifiée est la compression du temps. Prototypage par l’IA, génération de code, orchestration des parcours, conformité automatisée : toutes ces briques réduisent le temps entre l’idée, la mise en production et la monétisation. Dans un environnement de taux plus exigeant et de budgets plus contraints, cette compression est stratégique. Elle améliore la vitesse d’itération sans exiger nécessairement des hausses proportionnelles de headcount.

La troisième source de valeur est l’auditabilité. Plus les services financiers deviennent temps réel, plus la capacité à tracer une décision, un flux, une identité ou un contrôle devient importante. C’est là que les architectures événementielles, la conformité continue et certaines briques de sécurité prennent une valeur disproportionnée. Elles ne se contentent pas de réduire le risque ; elles rendent l’entreprise scalable dans un contexte réglementaire plus dense.

Les risques que les investisseurs sous-estiment encore

Premier risque : confondre adoption de l’IA et création de moat. Beaucoup d’équipes peuvent désormais produire des démos convaincantes. Peu savent gouverner la donnée, superviser le code généré, mesurer la dérive de performance ou gérer le risque réglementaire associé à des agents autonomes. L’écart entre la démonstration et l’industrialisation reste considérable.

Deuxième risque : sous-estimer la pression réglementaire européenne. AI Act, DORA, MiCA, DSP3, FiDA, eIDAS 2.0 : cette superposition de textes change profondément l’ordre des priorités. Les sociétés qui intègrent tôt la conformité dans leur architecture peuvent gagner du temps commercial et rassurer plus vite leurs partenaires institutionnels. Celles qui traitent encore la conformité comme une couche ajoutée après coup accumulent de la dette organisationnelle.

Troisième risque : mal arbitrer le build versus buy. Le radar montre que certaines briques sont assez mûres pour être achetées, notamment lorsqu’elles réduisent le time-to-market sur des couches non différenciantes. Mais il suggère aussi qu’à mesure qu’une FinTech mûrit, l’internalisation de briques plus centrales peut redevenir rationnelle pour récupérer de la marge, du contrôle et de la flexibilité. Pour un CVC, cela veut dire qu’il faut juger une startup non seulement sur son produit actuel, mais aussi sur la part de sa chaîne de valeur qu’elle pourra réellement maîtriser demain.

Lecture Europe et implications pour un CVC international

Même si le rapport est ancré dans l’écosystème français et européen, sa lecture dépasse largement ce périmètre. L’Europe agit ici comme laboratoire avancé d’une finance plus réglementée, plus interopérable et plus exigeante sur la traçabilité. Pour un investisseur actif entre Europe, Luxembourg, France et hubs comme Singapour, l’intérêt n’est pas seulement de suivre les tendances locales, mais de comprendre quelles briques européennes peuvent devenir exportables ou au contraire rester dépendantes du cadre réglementaire de l’Union.

Sur les sujets Open Finance, identité numérique, conformité automatisée et résilience opérationnelle, l’Europe produit souvent les contraintes avant de produire les standards. Pour un CVC disposant d’une connectivité forte avec l’Asie du Sud-Est, cela crée une opportunité : identifier tôt les solutions capables d’opérer dans l’environnement européen le plus dense, puis évaluer leur capacité à s’adapter à des marchés plus fragmentés mais plus rapides à exécuter. C’est un angle particulièrement intéressant pour les plateformes d’infrastructure, les outils de gouvernance IA, les briques KYC/KYB, la fraude et le compliance tooling.

En revanche, il faut rester critique. Toutes les innovations européennes ne voyageront pas bien. Certaines sont trop dépendantes de schémas réglementaires spécifiques, de coûts d’intégration élevés ou d’une complexité de distribution institutionnelle. La bonne lecture cross-border n’est donc pas “ce qui marche en Europe marchera partout”, mais “ce qui survit à l’Europe possède souvent une densité de conformité et de robustesse exportable”.

Les technologies à surveiller de près dans les 24 prochains mois

Parmi les signaux les plus prometteurs, trois familles ressortent. D’abord, les outils d’industrialisation IA : développement agentique, RAG, workflows agentiques maîtrisés, gouvernance des contextes et supervision des agents. Ensuite, les briques de confiance embarquée : passkeys, compliance as code, conformité continue, sécurité IA, zero trust. Enfin, les infrastructures ouvertes et modulaires : open banking data aggregation, event-driven architecture, portails développeurs et, à moyen terme, certaines couches d’Open Finance.

À l’inverse, le radar invite à la prudence sur les technologies qui séduisent plus par le récit que par le rendement immédiat. Les micro front-ends, le low-code/no-code traditionnel ou la RPA ne sont pas présentés comme des priorités stratégiques en 2026. Ce n’est pas un rejet dogmatique, mais un rappel utile : dans des organisations financières sous pression de coûts, toute technologie doit désormais prouver qu’elle simplifie réellement l’exploitation, accélère la mise en marché ou renforce la conformité.

Enfin, certaines briques classées en Assess méritent une veille serrée plutôt qu’un enthousiasme aveugle. La tokenisation, le zero knowledge proof, le chiffrement homomorphe, l’identité numérique européenne ou le cloud souverain peuvent devenir structurants, mais leur temporalité d’investissement dépendra fortement de la standardisation, de la maturité des cas d’usage et de la qualité des intégrations.

Conclusion : le bon réflexe n’est plus d’innover plus, mais d’arbitrer mieux

Le FinTech Radar 2026 ne dit pas que toutes les FinTech doivent courir après les mêmes sujets. Il dit quelque chose de plus exigeant et de plus utile : les organisations performantes sont celles qui savent distinguer les briques immédiatement actionnables de celles qui relèvent encore de la veille, du test ou du récit. Pour les investisseurs et CVC, cette grille est précieuse car elle aide à lire la maturité réelle derrière les narratifs de marché.

La meilleure opportunité d’investissement ne se situe pas forcément sur la technologie la plus spectaculaire. Elle se trouve souvent à l’intersection de trois éléments : une douleur métier intense, une intégration profonde au workflow client et une capacité prouvée à opérer dans un cadre conforme. C’est là que se construit la valeur durable.

En clair : en 2026, la frontière entre innovation et exécution s’efface. Les meilleurs actifs FinTech seront ceux qui transforment la sophistication technologique en fiabilité opérationnelle, en adoption commerciale et en avantage réglementaire. Ceux-là méritent vraiment l’attention du capital stratégique.

FAQ SEO

Qu’est-ce que le FinTech Radar 2026 ?

Le FinTech Radar 2026 est une cartographie de 40 innovations technologiques dans les services financiers, structurée par niveaux de maturité - Adopt, Trial, Assess, Hold - afin d’aider les décideurs à prioriser leurs choix d’adoption.

Pourquoi ce radar est-il utile pour un investisseur ou un CVC ?

Parce qu’il ne se contente pas d’énumérer des tendances. Il hiérarchise les technologies selon leur degré de maturité opérationnelle et met en lumière les sujets capables de créer un avantage concurrentiel réel dans la finance.

Quelles innovations FinTech semblent les plus mûres en 2026 ?

Le radar classe notamment en Adopt le prototypage par l’IA, les design systems, le développement agentique, le RAG, l’Open Banking data aggregation, le BaaS, les passkeys, le compliance as code et la conformité continue.

Quels sujets demandent encore de la prudence ?

La tokenisation, l’Open Finance, l’identité numérique européenne, les preuves à divulgation nulle de connaissance et le chiffrement homomorphe sont stratégiques, mais encore à surveiller ou à tester selon les cas d’usage et la maturité marché.

Why Flexibility Matters in Venture Support Models for Scale-Ups

Scaling a fintech or insurtech venture isn’t a straight line. You face shifting risks, evolving priorities, and constant pressure to accelerate growth without losing control. That’s why flexible venture support matters: it helps you manage uncertainty, speed execution, and keep your options open. In this post, you’ll see how a hybrid investment model tailored to your stage and needs can make a real difference in your scale-up growth. For more insights, you can explore this resource.

The Importance of Flexibility in Venture Support

Flexible venture support is crucial for navigating the unpredictable path of scaling up. It allows adjustments to shifting market conditions, aligning with the unique needs of each venture.

De-risking Through Adaptability

Adaptability in venture support minimizes risks associated with market volatility. When support structures can adjust, they help your business remain stable in turbulent times. For instance, flexible capital terms could allow for shifting investment levels based on performance metrics rather than rigid timelines. This approach can help absorb shocks and seize new opportunities. By tailoring support to your specific stage and market conditions, you're better equipped to handle unexpected changes without derailing progress.

Accelerating Execution with Tailored Support

Tailored support accelerates your execution by providing the right resources and expertise exactly when needed. It's about matching the pace of your growth with aligned support mechanisms. A customized approach ensures that resources flow smoothly, aligning with your strategic goals. For example, having access to industry experts or operational advice can hasten market entry and expansion, making your growth trajectory more efficient. The key is to provide support precisely where it can have the most impact, removing bottlenecks and driving momentum.

Preserving Optionality for Growth

Maintaining optionality is vital for long-term success. A flexible model keeps multiple paths open, allowing pivoting or scaling when the situation demands. This flexibility means your venture can explore new avenues without being locked into a single trajectory. Keeping options open allows for innovation and adaptation, ensuring that your business can evolve alongside market demands. It's not just about reacting to change; it's about proactively managing your growth pathways to maximize potential.

Key Components of a Flexible Model

A solid flexible model incorporates elements that adapt to your business's evolving needs. These components provide the framework for dynamic growth.

Tailored Capital Structure

A tailored capital structure aligns financial resources with growth stages, providing the right support when needed. This means structuring investments to meet your specific requirements, whether through equity, debt, or hybrid models. Such flexibility in financing ensures that your venture isn't stretched thin at critical moments. Tailoring capital means you can scale investment levels to align with performance and market conditions, ensuring your financial strategy supports your growth ambitions effectively.

Agile Governance Design

Agile governance design incorporates flexibility into decision-making processes, allowing for quick adaptations as circumstances change. This means establishing governance frameworks that can pivot when necessary, enabling more rapid responses to new information or market shifts. Agile governance empowers your leadership team to make timely decisions, improving overall strategic execution. By fostering a culture of adaptability, you can ensure that governance structures support innovation and growth, rather than stifling them.

Strategic Operating Cadence

Strategic operating cadence involves setting a rhythm that balances execution speed with thoughtful planning. It's about maintaining a tempo that matches your growth ambitions while allowing for necessary adjustments. Establishing this cadence ensures consistent progress, with room for evaluation and recalibration. A well-defined operating cadence aligns teams on priorities and timelines, providing clarity and focus. This balance is crucial for maintaining momentum without sacrificing strategic oversight.

Mandalore Partners' Approach to Scale-Up Growth

Mandalore Partners offers a comprehensive approach to supporting scale-up growth with flexibility and hands-on partnership.

Hybrid Investment Model and Venture Studio Execution

The hybrid investment model combines traditional funding with venture studio methodologies, offering a unique blend of capital and operational support. This model enables startups to access both financial resources and strategic guidance, facilitating faster and more efficient scaling. The venture studio approach provides shared resources and expertise, reducing barriers to growth. By integrating these elements, Mandalore Partners ensures that your venture receives the comprehensive support needed to thrive.

Value Creation Plan and Strategic Partnerships

A strong value creation plan is central to Mandalore Partners' strategy, focusing on building sustainable growth through strategic partnerships. Collaborations with industry leaders and experts provide access to critical insights and networks. These partnerships enhance your venture's capabilities, positioning you for success in competitive markets. By aligning value creation efforts with strategic goals, Mandalore Partners helps you achieve measurable outcomes and long-term impact.

Co-Investment Opportunities and Founder-Centric Partnership

Mandalore Partners emphasizes a founder-centric approach, offering co-investment opportunities that align with your vision and goals. This partnership model ensures that your interests are prioritized, fostering a collaborative environment for mutual success. Co-investments provide additional resources and risk-sharing, enhancing your venture's potential for growth. By prioritizing the founder experience and aligning with strategic objectives, Mandalore Partners creates a supportive ecosystem for entrepreneurial success.

Frequently Asked Questions

What is a hybrid investment model?
A hybrid investment model combines traditional venture capital with operational support, often through a venture studio approach. It provides financial resources alongside strategic and operational guidance, enabling startups to grow more effectively.

How does flexible governance benefit a startup?
Flexible governance allows a startup to adapt its decision-making processes in response to changing conditions. This agility helps in making timely and informed decisions, promoting faster adaptation to new opportunities or challenges.

What are the benefits of strategic partnerships in venture growth?
Strategic partnerships provide access to new markets, technologies, and expertise. They enhance a venture's capabilities and competitive position, facilitating growth and long-term success. These partnerships also offer networking opportunities and valuable industry insights.

Corporate Venture Capital in FinTech: A Practical Playbook for Financial Institutions

Europe's fintech sector now counts roughly 10,000 companies, making it the world's second-largest fintech ecosystem behind North America — yet the sector faces a structural funding gap that opens a real opportunity for strategic investors. European pension funds allocate less than 0.02% of assets to venture capital, compared with 1.9% in the US, leaving many promising fintechs dependent on US investors for growth-stage rounds. At the same time, 2026 marks the start of intensive enforcement for a stack of EU financial regulation — DORA, PSD3, MiCA, the AI Act and the incoming AMLA — that is reshaping what it takes to back a fintech well. For banks, insurers and financial institutions considering a corporate venture capital program, fintech is not simply another sector to add to a generalist mandate. It calls for its own playbook.

Why FinTech Is a Distinct Corporate Venture Opportunity

Embedded finance — banking, payments and credit built directly into non-financial platforms — has become the primary growth vector for European fintech, and increasingly the default model for B2B players. The logic is structural: customer acquisition is delegated to the distribution partner, part of the regulatory burden is shared or absorbed by that partner, and the capital required to reach scale drops sharply because each new partner acts as a distribution multiplier. For a corporate investor with an existing customer base, balance sheet, or distribution network, that structure is precisely where strategic capital adds more than money — an advantage a purely financial investor cannot replicate.

The Regulatory Load Is Becoming the Opportunity, Not Just the Obstacle

Four overlapping EU frameworks now define the compliance perimeter for fintech, with enforcement intensifying through 2026:

• DORA (Digital Operational Resilience Act) — in force since January 2025, sets detailed ICT risk management, incident reporting and operational resilience requirements for financial entities and their technology providers.

• PSD3 / the new Payment Services Regulation — reached political agreement in November 2025 and tightens open banking, fraud prevention and customer authentication standards, with dozens of implementing technical measures due through 2026.

• MiCA (Markets in Crypto-Assets) — now fully in force, has already prompted a wave of crypto-asset firms to seek EU licensing or exit the market.

• AMLA — a new EU-level anti-money-laundering authority replacing a fragmented patchwork of national enforcement.

The practical effect is that compliance readiness has become a genuine competitive moat rather than a cost center: enterprise customers now vet fintech vendors on MiCA and DORA readiness the way they once vetted uptime SLAs, and well-compliant players are winning enterprise deals against otherwise well-funded competitors who treated compliance as a deferred cost. For a corporate investor from within financial services, this regulatory fluency is a genuine source of diligence edge over generalist funds.

What Corporate Investors Bring to FinTech Specifically

The strategic value a financial institution can offer a fintech portfolio company differs meaningfully from what a generalist VC brings, and from what a corporate investor offers in most other sectors:

• Regulatory and licensing insight — financial institutions live inside the same compliance perimeter their portfolio companies are navigating, and can meaningfully shortcut diligence on regulatory risk that a generalist fund would need to outsource to external counsel.

• Trust and balance-sheet credibility — a strategic backer with an existing banking or insurance license lowers a fintech's perceived counterparty risk with its own enterprise customers, which matters disproportionately in financial services sales cycles.

• Distribution access — an existing customer base is often the fastest path to the scale that embedded-finance business models depend on, turning a single strategic investor into a meaningful growth channel rather than a passive check-writer.

• Talent and product credibility — secondments, technical reviews and product feedback from a corporate's own compliance, risk and product teams are often more valuable to an early-stage fintech than the capital itself.

This is also why fintech portfolio construction tends to reward a narrower, more sector-fluent mandate over a broad, opportunistic one: the diligence edge a financial institution holds is specific to financial services, and dilutes quickly once a program drifts into adjacent but unrelated verticals.

Build, Partner, or Delegate: The FinTech-Specific Version of the Question

The build-versus-delegate decision that applies to any corporate venture program is sharper in fintech, because the diligence bar is higher: evaluating a fintech well requires reading regulatory exposure (DORA, PSD3, MiCA) alongside standard venture metrics, a combination most generalist investment teams are not built for. Some financial institutions build this expertise in-house over time. Others delegate sourcing and diligence to a specialist manager while retaining a seat on the investment committee — a path that has a well-documented precedent in the market: AXA's corporate venture arm, AVP, began as a captive investment vehicle before evolving into an independently operating fund that now attracts outside limited partners, a maturation path several insurance and financial services groups have since followed in some form.

Where FinTech Deal Flow Is Concentrated

The UK remains the clear center of gravity for European fintech funding, raising over €6.1 billion in 2025 — more than half of total EU fintech funding — with Germany and France as the next-largest markets. Within that flow, B2B fintech is gaining ground on consumer-facing models, offering more defensible unit economics and clearer paths to enterprise-grade compliance readiness. For a corporate investor building a sourcing strategy, this means the UK, Germany and France collectively account for the large majority of addressable deal flow, even as strong pockets of activity continue to emerge across the Nordics and Southern Europe.

A related, structural point matters for sourcing strategy: European fintechs frequently raise early rounds domestically but turn to US investors for growth-stage capital, since European pension funds allocate a fraction of the venture capital that their US counterparts do. A European corporate investor able to write a credible growth-stage check is therefore competing for allocation against a comparatively thin pool of domestic alternatives — a structural advantage worth factoring into ticket-size planning from the outset, rather than defaulting to seed-stage tickets by convention.

Common Pitfalls for FinTech Corporate Venture Programs

Treating fintech as a generic tech vertical — and applying the same diligence checklist used for SaaS or consumer apps, missing regulatory exposure that a financial-services-fluent reviewer would catch immediately.

• Underestimating the AMLA and DORA compliance timeline — for portfolio companies, which can materially affect a startup's runway and go-to-market speed independent of its product execution.

• Competing on capital alone — in a sector where distribution and regulatory credibility are usually worth more to founders than an incremental point of valuation.

• Over-concentrating in consumer-facing fintech — while the more durable growth, per recent market analysis, is increasingly in B2B and embedded finance models with clearer paths to compliant scale.

Frequently Asked Questions

Is fintech corporate venture capital only relevant for banks?

No. Insurers, payment processors, asset managers and other regulated financial institutions all have a comparable strategic rationale — regulatory fluency, distribution access and balance-sheet credibility apply across financial services, not only to banks.

How does a fintech-focused CVC program differ from an InsurTech-focused one?

Both benefit from sector-specific regulatory expertise, but the underlying diligence skill sets differ: fintech investing leans heavily on payments, banking and crypto-asset regulation (DORA, PSD3, MiCA), while InsurTech investing leans on actuarial understanding and insurance-specific rules such as Solvency II and the IDD. Institutions active in both areas typically need access to both skill sets rather than treating them as interchangeable.

Does DORA apply to a corporate investor itself, or only to the fintech being backed?

DORA applies to in-scope financial entities and their critical ICT third parties. Whether and how it applies to a specific corporate investor's own operations depends on its regulatory status and should be confirmed with compliance counsel — but at minimum, portfolio companies' DORA readiness is a legitimate and increasingly standard diligence item.

Why is embedded finance particularly relevant to corporate investors?

Embedded finance business models rely on distribution partners to reach scale efficiently. A corporate investor that can offer its own distribution — a customer base, a sales channel, a platform — is often uniquely positioned to accelerate exactly the growth mechanism these companies depend on, beyond the capital itself.

Conclusion

FinTech rewards corporate investors who bring genuine regulatory fluency and distribution value, not just capital — and penalizes generalist approaches in a sector where compliance complexity is now a competitive moat rather than a checkbox. For financial institutions building a strategic investment approach to the sector, the question is less whether to engage with FinTech innovation and more whether to build that regulatory and sourcing expertise internally or access it through a specialist partner.

How to Launch a Corporate Venture Capital Program: A Step-by-Step Guide

Corporate venture capital enters the second half of 2026 on unusually solid footing. The number of active corporate investors reached a record 3,068 globally in 2025, up 29% year-on-year and surpassing even the 2021 peak, with 46 new CVC units launched during the year. Corporate investors took part in 5,221 startup funding rounds — up 30% — and disclosed deal value rose 75% to $233.8 billion, even as overall venture capital activity cooled. For executives weighing whether to build a corporate venture arm, the strategic case has rarely been stronger. What is far less obvious is how to structure one well. This guide walks through the decisions that actually determine whether a CVC program becomes a durable strategic asset or a well-intentioned pilot that quietly winds down.

Why Now: CVC as a Countercyclical Force

The 2026 Global Corporate Venturing survey describes corporate venture capital as an increasingly countercyclical force in the innovation economy: as traditional VC-backed funding rounds declined from roughly 30,000 in 2024 to just over 25,000 in 2025, corporate-backed deal value moved sharply in the opposite direction. Scale is not the entry ticket it might appear to be, either — more than half of CVC units globally manage under $100 million and make six or fewer investments a year. Quality of execution, not fund size, is what separates programs that compound strategic value from those that don't.

Step 1: Define Your Strategic Thesis

Every downstream decision — structure, team, governance, ticket size — flows from one question: what is this program actually for? Broadly, CVC programs are built around three objectives, often blended: financial return, strategic access (technology, talent, market intelligence), and ecosystem signaling (positioning the parent company as an innovation partner of choice). Programs that never resolve this question tend to drift, satisfying none of the three well.

Step 2: Choose Your Operating Model

There is no single correct structure — the right one depends on the thesis defined in step one.

• Direct investment — the corporate invests from its own balance sheet or a dedicated subsidiary, deal by deal. Fast to start, full control, but capital deployment is tied to the parent's own risk appetite and budget cycles.

• A dedicated fund vehicle — a ring-fenced fund with its own governance, sometimes open to outside LPs. Slower to set up, but creates clearer separation from the parent and a more professional footing for co-investors and founders alike.

• LP positions in external funds — a lower-commitment entry point that is more common than many first-time corporate investors assume — more than half of CVC units globally hold LP positions in other venture funds, using them as both a return stream and a sourcing channel.

Many mature programs combine more than one: direct deals for strategic priorities, LP positions for broader market visibility. What matters most is that the choice is made deliberately, against the thesis from step one, rather than defaulted to because it is what a peer company happens to run — the right structure for a defensive, technology-scouting mandate is often the wrong one for a program built primarily to generate financial return.

Sizing is a related, frequently mishandled decision. There is no universal benchmark ticket size: first checks credibly range from a few hundred thousand euros at seed stage to double-digit millions at growth stage, and more than half of CVC units globally manage a total portfolio under $100 million. The more useful planning question is not "how much should we allocate," but "how many credible investments does our thesis require to generate a meaningful strategic or financial signal" — and sizing the budget to that number, rather than to an arbitrary round figure set by finance.

Step 3: Decide Whether to Build, Partner, or Delegate

Building a full internal venture team — sourcing, diligence, portfolio support, legal and fund operations — typically takes three to five years to reach professional maturity, a timeline that discourages many corporates from starting at all. An increasingly common alternative is to delegate day-to-day sourcing and portfolio management to an external, specialist manager while the corporate retains an investment committee seat and strategic control — a model often described as venture-capital-as-a-service. This tends to compress the time to a credible first investment from years to months, at the cost of some operational control that a fully in-house team would retain.

Step 4: Design Governance Before the First Term Sheet

Board or observer participation in portfolio companies is now standard practice for CVC units globally, not an exception. Decision rights, information access, follow-on policy and exit alignment should all be agreed at the program level before the first deal closes — negotiating these principles one term sheet at a time is a common source of both slow decision-making and founder frustration, and slow decision-making is the single most common reason corporate investors lose competitive deals to funds that can move in weeks rather than quarters.

Step 5: Build a Real Deal-Flow Engine

A credible pipeline rarely appears on its own. The programs that source well typically combine several channels deliberately: direct origination through the parent's own industry network, co-investment relationships with financial VCs who value a strategic partner at the table, LP positions in funds that generate proprietary look-backs, and — where relevant — accelerator or innovation-hub partnerships. Cold, generic sourcing is the most common reason new CVC programs describe their first eighteen months as slower than expected.

Step 6: Design Real Value Creation, Not Just Capital

The differentiator that founders consistently cite when choosing a corporate investor over a purely financial one is genuine commercial engagement — not the size of the check. Globally, 47% of CVC units report that at least half of their portfolio companies have active commercial engagement with the parent company: pilot programs, distribution partnerships, technical integration, or supplier relationships. Programs that treat this as a core design question from the outset — rather than an occasional, opportunistic bonus — build far more defensible strategic value over time.

How to Measure Success

Financial metrics (TVPI, IRR) remain necessary but are rarely sufficient on their own for a corporate program. Leading CVC units increasingly benchmark themselves on a blended scorecard: financial return, strategic return (partnerships, technology access, market intelligence generated), and portfolio commercial engagement rate. Industry benchmarking resources — such as the annual GCV Keystone survey, which now draws on data from nearly 400 CVC units worldwide — offer a useful external reference point rather than relying on internal targets alone.

Common Reasons CVC Programs Underperform

• No resolved strategic thesis — the program tries to serve financial return, strategic access and signaling equally, and ends up optimizing for none of them.

• Decision speed misaligned with the market — quarterly investment committees lose deals to funds that can issue a term sheet in days.

• Governance negotiated deal by deal — rather than agreed once, at the program level, before the first investment.

• Value creation left to chance — rather than designed in as a deliberate, resourced function alongside the investment process itself.

• Benchmarking against internal targets alone — rather than external industry data, which makes it difficult to tell whether a program is genuinely underperforming or simply operating within a normal range for its size and stage.

Frequently Asked Questions

How long does it take to launch a corporate venture capital program?

A direct-investment program can make its first deal within a few months of a resolved thesis and mandate. A fully built internal team with proprietary deal flow typically takes three to five years to reach professional maturity; delegating sourcing and portfolio management to an external manager can compress this significantly.

What is a realistic first-year budget for a CVC program?

There is no universal figure, since more than half of CVC units globally manage under $100 million in total, and first checks can range from a few hundred thousand to several million depending on stage and sector. The strategic thesis should drive budget sizing, not the reverse.

Do we need a dedicated fund vehicle, or can we invest directly?

Direct, balance-sheet investment is faster to start and preserves full control, but limits the ability to bring in outside co-investors later. A dedicated fund vehicle takes longer to set up but is generally preferred for larger, longer-horizon programs intended to scale beyond a handful of deals a year.

How is a corporate venture program different from simply being an LP in venture funds?

They are complementary rather than mutually exclusive. LP positions provide market visibility, deal-flow look-backs and diversified financial exposure with a lighter operational footprint; direct investment allows for deeper strategic engagement with individual portfolio companies. More than half of active CVC units globally do both.

Conclusion

The market conditions favoring corporate venture capital in 2026 are unusually clear: rising deal value, a countercyclical role as traditional VC activity cools, and a growing body of shared industry practice on what separates strong programs from stalled ones. What remains company-specific is the discipline to resolve the strategic thesis, choose the right operating model, and design governance and value creation deliberately — rather than improvising them deal by deal.

Corporate Venture Capital in France: A Practical Guide to Structuring Your CVC Program

France's venture capital market opened 2026 with its strongest first half since the pandemic recovery: roughly €4.6 billion raised in H1 alone, up 65% year-on-year, driven by large rounds in AI, quantum computing and defense technology. For corporates watching this momentum from the sidelines, the question is no longer whether to engage with the French startup ecosystem, but how. Corporate venture capital (CVC) is the most direct way to do it — yet most of the practical guidance available today is either generic (written for a US or UK audience) or scattered across regulator filings and association member portals. This guide brings the pieces together: the state of CVC in France today, the institutions that shape the ecosystem, the legal structuring choices, and a step-by-step path to launching a program.

The State of Corporate Venture Capital in France in 2026

French venture capital overall is in a strong cycle. According to EY's H1 2026 barometer, the market raised approximately €4.6 billion in the first six months of the year, a 65% increase compared to the prior period, with megarounds in foundation models, quantum computing and defense technology driving much of the growth. Île-de-France alone accounts for more than 80% of amounts raised, reflecting the continued concentration of the ecosystem around Paris.

Corporate venture capital is a meaningful, if still underweighted, part of that picture. Independent market mapping puts corporate VC vehicles at roughly one in ten of the active investment funds in the French market — a smaller share than in the US, but a growing one. Groups such as Orange, LVMH, Safran, Sanofi, Bouygues and Michelin all run dedicated corporate venture arms today, alongside dozens of smaller, sector-focused programs. Bpifrance's own research has long described French corporate venture as historically under-professionalized relative to its US counterpart — a gap that is closing as more groups treat CVC as a discipline rather than a side project.

Why France Specifically?

Three features make France a distinctive environment for corporate venture capital, compared to neighboring markets.

• A structuring public investor — Bpifrance plays a dual role with no direct equivalent elsewhere in Europe: it invests directly across stages through vehicles such as Bpifrance Digital Venture (early-stage, roughly €1.1 billion under management since 2011) and Bpifrance Large Venture (a €2.5 billion growth fund), while also acting as a limited partner across dozens of private VC and corporate venture funds.

• A concentrated, deep-tech-heavy pipeline — France's 2026 deal flow skews toward AI, quantum computing, defense and climate technology — sectors where corporate strategic capital (not just financial capital) is often the deciding factor for founders choosing between term sheets.

• An organized professional community — France Invest, the French private equity and venture capital association, runs a dedicated Club CVC bringing together corporate venture practitioners, alongside a Venture & Growth Commission that publishes shared best-practice guides.

Three Institutions Every CVC Program Should Know

Bpifrance

Bpifrance is France's public investment bank and the most active single participant in the French venture ecosystem. For a corporate building a CVC program, it is relevant in three ways: as a potential co-investor in deals, as an LP that many independent VC funds share as an investor, and as a source of shared practice — Bpifrance Le Hub publishes CVC benchmarks and governance guidance developed with legal practitioners and corporate venture teams across the market.

France Invest

France Invest is the professional body representing private equity and venture capital players in France. Its Club CVC is the natural entry point for a newly formed corporate venture team: a peer community for benchmarking ticket sizes, governance models and legal structures against other corporates already running programs, from large groups to newer entrants.

The AMF (Autorité des Marchés Financiers)

The AMF is France's financial markets regulator. It authorizes and supervises the "sociétés de gestion de portefeuille" (portfolio management companies) that manage regulated collective investment vehicles, including the fund structures — FCPR, SCR and similar — most often used for venture investing in France. Whether a CVC program needs to deal with the AMF at all depends heavily on the legal structure chosen, which is the next question to resolve.

This section is general educational information, not legal or regulatory advice — any corporate evaluating a French CVC structure should confirm specifics with qualified legal counsel before proceeding.

Legal Structuring Options for a French CVC Program

Direct, Balance-Sheet Investment

The corporate invests directly from its own balance sheet, or through a dedicated holding subsidiary, without managing outside investors' capital. Because no collective investment vehicle is being run on behalf of third parties, this route generally does not trigger AMF authorization as a portfolio management company. It is the fastest route to a first deal and preserves full strategic control, at the cost of limited ability to bring in outside co-investors later and an investment pace tied to the parent's own capital allocation appetite.

A Dedicated Fund Vehicle (FCPR / SCR)

Larger or longer-horizon programs are often structured as a regulated fund — typically a fonds commun de placement à risque (FCPR) or société de capital-risque (SCR) — run by an AMF-authorized management company, either built in-house or delegated to an external manager. This route allows outside LPs to co-invest alongside the corporate, creates clearer governance separation between the fund and the parent group, and is generally viewed more favorably by professional co-investors and target companies alike. It also comes with materially more setup complexity: an AMF authorization process, ongoing regulatory reporting, and the operational cost of running a licensed structure.

The Tax Dimension

France offers a fiscal incentive relevant to corporate venture specifically: qualifying minority investments in innovative SMEs — generally up to a 20% stake — can be amortized for tax purposes over five years. This mechanism was designed to encourage exactly this type of corporate investment, but eligibility conditions are specific and should be validated with tax counsel before a program is structured around it.

Step-by-Step: Launching a CVC Program in France

• 1. Define the strategic thesis — financial return, strategic access (technology, talent, market intelligence), or a deliberate blend — and which sectors and stages the program will target. This choice drives every structuring decision that follows.

• 2. Choose the legal structure — direct balance-sheet investment for speed and control, or a dedicated FCPR/SCR fund vehicle for scale, co-investment and governance separation — see the comparison above.

• 3. Build or delegate the investment team — many corporates delegate day-to-day sourcing and portfolio management to an external, professional manager while retaining an investment committee seat, rather than building a full internal VC team from scratch.

• 4. Plug into the ecosystem — Bpifrance co-investment programs, France Invest's Club CVC, and regional innovation networks are the fastest way to build a credible deal-flow pipeline rather than starting cold.

• 5. Design real value-creation mechanisms — commercial access, technical expertise and market credibility, not capital alone — the single biggest differentiator founders cite when choosing a corporate investor over a purely financial one.

• 6. Set governance and exit rules from day one — decision rights, information access, follow-on policy and exit alignment should be agreed before the first term sheet, not negotiated deal by deal.

Common Pitfalls

• Treating CVC as an innovation-watch function — rather than a genuine investment discipline with real decision authority — a pattern Bpifrance's own market research has flagged as a recurring weakness of under-professionalized programs.

• Decision speed misaligned with startup expectations — a corporate investment committee that meets quarterly will lose competitive deals to funds that can move in weeks.

• No governance framework until it's needed — exit rights, follow-on policy and information rights are far easier to agree upfront than to renegotiate mid-relationship.

• Underestimating the AMF timeline — for programs structured as a regulated fund vehicle, authorization is a multi-month process that should be planned for, not discovered.

Frequently Asked Questions

Does every corporate venture program need AMF authorization?

No. Direct, balance-sheet investment generally falls outside AMF licensing requirements because no third-party capital is being managed. AMF authorization becomes relevant when the program is structured as a regulated collective investment vehicle, such as an FCPR or SCR.

How is Bpifrance's role different for corporate venture specifically, compared to venture capital generally?

Bpifrance supports the broader VC market as both a direct investor and an LP, but it also runs CVC-specific initiatives — including shared best-practice research through Bpifrance Le Hub — aimed at helping corporates professionalize their venture programs rather than treating them as a side function.

What is a typical minimum ticket size for a French CVC program?

This varies widely by sector and sponsor, and there is no single market standard; programs range from a few hundred thousand euros at seed stage to double-digit-million tickets at growth stage. The strategic thesis defined at the outset should drive ticket sizing, not the reverse.

Can non-French corporates access this ecosystem the same way?

Yes — international groups run CVC programs targeting French startups today, and can invest directly or set up a French vehicle. The main practical difference is that a French legal and regulatory structure (and, where relevant, French fund counsel) is generally required to operate through a fund vehicle rather than direct cross-border investment.

Conclusion

France's 2026 funding rebound, its unusually active public investor in Bpifrance, and an organized professional community around France Invest's Club CVC together make it one of the more structured environments in Europe for launching a corporate venture program — provided the legal structuring choice, governance model and ecosystem access are set up deliberately rather than improvised deal by deal.

Reduce Execution Friction in Early-Stage Growth: A Founder’s Operating Playbook

Execution friction can stall your startup’s momentum just when growth demands speed. Early-stage scaling becomes a challenge when priorities blur and decisions drag. This founder operating system breaks down how to design your startup operating cadence, sharpen governance for startups, and cut through bottlenecks to move faster. Keep reading to build a clearer path to steady, scalable execution. https://entrepreneurship.asu.edu/blog/2026/01/15/five-growth-strategies-every-early-stage-startup-should-explore-in-2026/

Identifying Execution Friction

When startups face execution friction, progress halts. Identifying these hurdles is crucial for maintaining momentum. Let's explore common barriers and how to tackle them effectively.

Pinpointing Common Barriers

Execution friction often arises from unclear priorities and misaligned teams. It's essential to recognize these signs early. Look for delayed decisions and stalled projects. These are indicators that your team may not be on the same page. Addressing these issues promptly can prevent further delays.

Another common barrier is communication breakdown. Ensure that all team members have access to the information they need. Regular updates and open channels can alleviate this issue. By fostering transparency, you can improve collaboration and efficiency.

Prioritizing Key Objectives

To overcome execution friction, prioritize your objectives. Identify which goals are most critical to your startup's success. Focus your resources and efforts on these key areas. This helps create clarity and direction for your entire team.

One method to prioritize effectively is using a simple scoring system. Rate each objective based on its impact and feasibility. This helps in making informed decisions about where to allocate your time and resources. Staying focused on priorities ensures consistent progress.

Aligning Team Efforts

Alignment within your team is vital for smooth execution. Make sure everyone understands the company’s vision and their role in achieving it. Conduct regular meetings to discuss goals and progress. This keeps everyone aligned and moving in the right direction.

Encourage feedback and open dialogue. When team members feel heard, they are more likely to be engaged and motivated. This collaborative approach reduces friction and fosters a cohesive working environment.

Establishing Startup Operating Cadence

Creating a structured operating cadence helps maintain focus and streamline processes. This section will explore how to establish an effective cadence for your startup.

Designing Effective Meeting Cadences

Meetings are a critical component of your operating cadence. Design meetings with clear agendas and outcomes. This ensures that time is well spent and decisions are made efficiently. Regularly scheduled check-ins can keep your team aligned and accountable.

Consider implementing a weekly team meeting to discuss progress and challenges. This helps in identifying potential bottlenecks early. Keeping meetings concise and focused ensures that they remain productive and valuable.

Implementing Governance for Startups

Governance is key to maintaining order and accountability. Establish clear roles and responsibilities within your team. This prevents overlaps and ensures that everyone knows their tasks.

Incorporate regular reviews to assess performance and address issues. This not only maintains transparency but also encourages continuous improvement. By implementing governance structures, you can enhance decision-making and execution.

Leveraging OKRs and KPIs

OKRs (Objectives and Key Results) and KPIs (Key Performance Indicators) are valuable tools for measuring progress. Define clear OKRs that align with your startup’s objectives. These provide a framework for tracking performance.

Regularly review KPIs to gauge success and identify areas needing attention. This data-driven approach helps in making informed decisions. It also ensures that your team stays focused on achieving their goals.

Accelerating Early-Stage Scaling

With a solid foundation in place, it's time to focus on scaling your operations. This section will cover strategies to boost growth and streamline processes.

Strategic Sprints and Resource Allocation

Strategic sprints can accelerate progress by focusing on specific goals. Break down projects into manageable tasks and set short deadlines. This approach maintains momentum and prevents stagnation.

Resource allocation is equally important. Ensure that your team has the tools and support they need. This enables them to work efficiently and deliver results. By optimizing resources, you can drive growth and achieve your objectives.

Utilizing AI Tools for Startups

AI tools can enhance efficiency and decision-making. Implement solutions that automate repetitive tasks and provide valuable insights. This frees up your team to focus on strategic activities.

Select tools that align with your startup’s needs. Evaluate their impact on productivity and cost-effectiveness. By leveraging AI, you can gain a competitive edge and accelerate growth.

Enhancing Go-To-Market Execution

A well-executed go-to-market strategy is crucial for success. Define your target market and tailor your approach accordingly. Utilize data and insights to refine your strategy and improve outcomes.

Regularly assess your go-to-market efforts to ensure alignment with your objectives. Make adjustments as needed to optimize results. By staying agile, you can adapt to changing market conditions and capitalize on new opportunities.

Frequently Asked Questions

What is execution friction in startups?

Execution friction occurs when misalignment or unclear priorities slow down a startup's progress. It can manifest as delayed decisions, stalled projects, or communication breakdowns, hindering growth and efficiency.

How can startups prioritize objectives effectively?

Startups can prioritize objectives by using a scoring system to evaluate impact and feasibility. Focusing on key objectives ensures resources are allocated effectively, driving progress and maintaining momentum.

Why is governance important for startups?

Governance establishes clear roles and responsibilities, preventing overlaps and enhancing accountability. It ensures transparent decision-making and encourages continuous improvement, vital for sustainable growth.

What role do AI tools play in startups?

AI tools automate repetitive tasks and provide insights, enhancing efficiency and decision-making. By selecting tools aligned with their needs, startups can gain a competitive edge and accelerate growth.

How can a go-to-market strategy be optimized?

A go-to-market strategy can be optimized by defining the target market and tailoring the approach. Utilizing data and insights to refine the strategy ensures alignment with objectives and adapts to market changes.

https://www.mandalorepartners.com/

Lean Corporate Venture Capital: Accelerating Innovation Without Bureaucracy

Corporate venture capital often gets tangled in layers of bureaucracy that slow decision-making and stifle innovation. You want a CVC operating model that accelerates learning and growth without adding red tape. This post explains how to design lean CVC programs that create strategic options and speed portfolio acceleration while maintaining clear governance and decision rights. Read on to learn practical steps for innovation without bureaucracy and why Mandalore Partners is the right partner to structure and run your program. [https://www.twofourseven.co.uk/blog/9/6/2026/why-corporate-venture-capital-is-doing-what-vc-cannot]

Lean CVC Fundamentals

Understanding the basics of lean corporate venture capital (CVC) is essential. These programs drive strategic growth and reduce bureaucratic hurdles, helping companies innovate faster and more effectively.

Driving Strategic Growth

Lean CVC programs are designed to foster innovation that aligns with your company's strategic goals. They focus on identifying and investing in startups that can fill gaps in your product offerings or expand your market reach. For example, a financial services company might invest in a fintech startup developing cutting-edge payment solutions.

Such investments allow companies to stay ahead of industry trends and adapt to changing market demands. By partnering with innovative startups, you gain access to new technologies and business models, which can be integrated into your existing operations. This approach not only enhances your competitive advantage but also ensures sustainable growth.

Reducing Bureaucratic Hurdles

One of the main challenges of traditional CVC programs is bureaucracy. It slows down decision-making and hinders the ability to seize opportunities quickly. Lean CVC programs, however, focus on streamlining processes and removing unnecessary layers of approval.

By implementing clear governance and decision rights, you can accelerate deal flow and reduce the time it takes to invest in promising startups. This agility is crucial in today's fast-paced business environment, where the ability to act quickly often determines success. Simplifying procedures and empowering teams to make decisions can lead to more efficient operations and better investment outcomes.

Case Study: Efficient CVC Models

Let's look at a case study of an efficient CVC model. A tech company streamlined its investment process by creating a dedicated CVC team with clear decision-making authority. This allowed them to quickly evaluate potential startups and make investments without the usual delays.

The result was a portfolio of high-performing startups that contributed significantly to the company's growth. The CVC team operated with the autonomy to make swift decisions, which enabled them to seize opportunities that would have been missed under a more bureaucratic system. This case demonstrates how lean CVC models can drive success through efficiency and strategic alignment.

Designing Effective CVC Programs

Creating a successful CVC program requires careful design and implementation. Key elements include governance, fast-lane compliance workflows, and strategies for accelerating portfolio growth.

Governance and Decision Rights

Effective governance is the backbone of any CVC program. It ensures that investments align with your company's strategic objectives and that risks are managed appropriately. Establishing clear decision rights is crucial to avoid bottlenecks and facilitate swift action.

You can achieve this by defining roles and responsibilities for the CVC team and setting up a streamlined approval process. This structure allows for quick decision-making while maintaining accountability. Regular reviews and updates to governance policies ensure that the program remains aligned with the company's goals.

Fast-Lane Compliance Workflows

Compliance is a necessary component of any investment program, but it shouldn't slow you down. Fast-lane compliance workflows can help you navigate regulatory requirements efficiently, enabling you to invest in startups without unnecessary delays.

These workflows involve automating routine compliance tasks and using technology to streamline the documentation process. By doing so, you ensure that compliance doesn't become a barrier to innovation. With the right systems in place, you can focus on identifying and supporting high-potential startups.

Portfolio Acceleration Strategies

Accelerating portfolio growth requires a strategic approach. This involves not only selecting the right startups to invest in but also providing them with the resources and support they need to succeed.

Your CVC program should include strategies for mentoring and supporting startups, such as access to your company's expertise, networks, and infrastructure. By nurturing these startups, you increase the chances of a successful exit and a positive return on investment. Regularly reviewing and adjusting these strategies ensures that your portfolio remains dynamic and aligned with market trends.

To implement lean CVC practices, focus on open innovation, pilot programs, and measuring success with innovation KPIs.

Open Innovation and Co-Investment

Open innovation encourages collaboration between your company and external startups. By co-investing in startups, you share the risks and rewards, fostering a culture of innovation.

This approach allows you to tap into a broader range of ideas and technologies, accelerating the development of new products and services. Co-investment also provides startups with the financial backing they need to grow, benefiting both parties.

Pilot Programs and Learning Velocity

Pilot programs are an effective way to test new ideas and technologies before fully committing. They allow you to evaluate the potential impact of a startup's solution on your business.

By running pilot programs, you can identify any challenges early on and make informed decisions about scaling up. This approach increases your company's learning velocity, enabling you to adapt quickly to new opportunities and challenges.

Measuring Success with Innovation KPIs

To ensure the success of your CVC program, it's crucial to measure performance using innovation KPIs. These metrics provide insights into the effectiveness of your investments and the impact of startups on your business.

Key KPIs might include the number of successful exits, return on investment, and the growth rate of portfolio companies. By regularly tracking these metrics, you can make data-driven decisions and continuously improve your CVC program.

Frequently Asked Questions

What is lean corporate venture capital?

Lean corporate venture capital focuses on reducing bureaucracy and streamlining processes to make faster, more effective investments in startups. It aims to align investments with strategic goals and foster innovation without unnecessary delays.

How can companies reduce bureaucracy in CVC programs?

Companies can reduce bureaucracy by implementing clear governance structures, defining decision rights, and streamlining compliance workflows. This allows for quicker decision-making and more efficient operations.

What are the benefits of open innovation in CVC programs?

Open innovation encourages collaboration between companies and startups, allowing for a broader range of ideas and technologies. It accelerates product development and provides startups with the support they need to grow.

How do pilot programs enhance learning velocity?

Pilot programs test new ideas and technologies on a smaller scale, allowing companies to learn and adapt quickly. They help identify challenges early, making it easier to decide on scaling successful initiatives.

What are innovation KPIs and why are they important?

Innovation KPIs are metrics used to measure the success of CVC programs. They help assess the impact of investments and guide decision-making to enhance overall program effectiveness.

Beyond the Check: How Active Value Creation Works in Corporate Venture Capital

Corporate venture capital often gets reduced to signing checks. But real progress depends on active value creation—governance, hands-on support, and clear KPIs that drive portfolio outcomes. At Mandalore Partners, we turn corporate strategy into measurable growth through disciplined execution in AI and insurtech ventures. This post breaks down how a structured, founder-centric approach outperforms passive investing and delivers lasting impact. For more insights, explore our research on active value creation in venture capital.

Understanding Active Value Creation

Active value creation in corporate venture capital (CVC) goes beyond monetary investments to ensure that startup growth aligns with strategic goals. Let's break down the essential elements.

Governance and KPIs in CVC

Governance in CVC involves setting clear objectives and measurable key performance indicators (KPIs) to track progress. This structured approach ensures alignment with corporate goals. When KPIs are well-defined, they serve as a compass for startups, guiding them toward meaningful achievements. Strong governance frameworks foster accountability and transparency, crucial for long-term success.

Implementing effective governance requires collaboration between CVC teams and startups. Regular meetings and performance reviews help maintain focus. By establishing robust governance, companies can mitigate risks and drive consistent growth. The use of KPIs ensures that both parties remain aligned and committed to shared goals.

Operating Models for Success

Effective operating models are essential for the success of any venture. They provide a roadmap for growth and adaptability. A well-structured model outlines processes and roles clearly, minimizing confusion. This clarity enables startups to focus on execution and innovation.

Successful operating models are flexible, allowing for adjustments as market conditions change. Adaptability is key, especially in fast-paced industries like fintech and insurtech. By establishing efficient processes early on, startups can scale operations smoothly, ensuring consistent performance and growth.

Post-Investment Support Strategies

Post-investment support is critical for startup growth. It involves providing guidance, resources, and connections that help startups navigate challenges. Hands-on support ensures that startups receive the assistance they need to overcome hurdles and seize opportunities.

Effective support strategies include mentorship programs, access to industry experts, and networking opportunities. These resources enable startups to refine their strategies and gain valuable insights. By offering comprehensive support, CVCs can significantly enhance startup success rates, leading to mutually beneficial outcomes.

Contrast with Passive Approaches

Active value creation stands in stark contrast to passive investing. Here's why hands-on involvement is crucial.

Importance of Hands-On Investing

Hands-on investing involves active participation in a startup's journey. Unlike passive approaches, it requires ongoing engagement and support. This active involvement enables investors to address challenges promptly and capitalize on opportunities.

By being actively involved, investors can offer guidance and resources that drive growth. This approach ensures that startups receive the support they need to succeed, leading to better outcomes for all stakeholders.

Portfolio Acceleration Techniques

Portfolio acceleration involves strategies that expedite growth and maximize value. These techniques include mentorship, resource sharing, and strategic partnerships. By leveraging these strategies, investors can help startups achieve rapid growth and increase their competitive edge.

Portfolio acceleration requires a proactive approach, with investors taking an active role in facilitating growth. This hands-on involvement ensures that startups remain agile and adaptable, allowing them to thrive in dynamic markets.

Founder-Centric Support Models

Founder-centric support models prioritize the needs of startup founders. This approach recognizes that founders are integral to a startup's success. By providing tailored support, investors can empower founders to lead their ventures effectively.

Founder-centric models involve personalized guidance, access to networks, and strategic advice. These resources enable founders to make informed decisions and drive their startups toward success. This approach fosters trust and collaboration, creating a strong foundation for growth.

Frequently Asked Questions

What is active value creation in CVC?
Active value creation in CVC involves providing more than just financial investment. It includes strategic guidance, governance, and measurable KPIs to drive startup growth aligned with corporate goals.

How does Mandalore Partners support startups?
Mandalore Partners supports startups through strategic guidance, operational support, and access to industry networks. This comprehensive approach ensures startups can navigate challenges and scale effectively.

Why is hands-on investing important?
Hands-on investing involves active participation in a startup's journey, offering ongoing support and resources. This approach enables investors to address challenges promptly and seize growth opportunities.

What are portfolio acceleration techniques?
Portfolio acceleration involves strategies that expedite growth, such as mentorship, resource sharing, and strategic partnerships. These techniques maximize value and enhance competitive advantage.

How do founder-centric support models benefit startups?
Founder-centric models prioritize the needs of startup founders, offering personalized guidance and resources. This approach empowers founders to lead their ventures effectively and drive success.

Creating a Co-Investment Framework That Preserves Discipline and Alignment

Co-investing without clear rules often leads to misaligned priorities and haphazard decisions. You need a co-investment framework that keeps your team disciplined while protecting your mandate and governance. This post outlines how to build that structure—from allocation policy to pacing limits—so your co-investments stay focused and aligned with your long-term goals. For further insight, you can explore this resource.

Designing a Co-Investment Framework

Understanding the inner workings of VCaaS is crucial for leveraging its full potential. This section explores how strategy, sourcing, and acceleration come together.

Structuring Strategy and Governance

A strong strategy and governance framework is essential in VCaaS. Providers like Mandalore Partners craft strategies that align with corporate goals, focusing on long-term value and impact. Governance structures are put in place to ensure transparency and accountability, enabling companies to make informed decisions while minimizing risks.

Sourcing and Due Diligence Process

Effective sourcing and thorough due diligence are the backbones of successful venture investments. VCaaS providers employ robust processes to identify promising startups and evaluate their potential. This involves market research, risk assessment, and financial analysis, ensuring that investments align with strategic objectives.

Portfolio Acceleration Techniques

Beyond initial investments, VCaaS focuses on accelerating portfolio growth. This includes providing operational support, strategic partnerships, and access to networks. By enhancing growth potential, VCaaS ensures that startups not only survive but thrive in competitive markets.

Benefits of Mandalore Partners' Approach

Continuing from establishing a solid framework, it's crucial to ensure ongoing alignment and discipline in your investments. Let's discuss some key practices.

Implementing Pro-Rata Rights and Policies

Pro-rata rights allow investors to maintain their ownership percentage in future funding rounds. This is vital for protecting your stake as a company grows. To implement these rights, negotiate terms during initial investments.

Develop clear policies on how additional funding will be managed. This includes deciding when to exercise pro-rata rights and how to handle dilution. Consistent policies ensure fair treatment of all investors.

Communication is key. Keep all stakeholders informed about funding decisions. Transparent communication builds trust and fosters a collaborative investment environment.

Monitoring ESG and Impact Metrics

Environmental, Social, and Governance (ESG) metrics are increasingly important. Monitoring these metrics ensures that investments align with impact goals. Begin by identifying key ESG indicators relevant to your investments.

Establish a system for tracking these metrics. Use software or third-party services to gather and analyze data. Regular reviews help assess performance and guide future decisions.

Integrate ESG considerations into decision-making processes. This ensures that all investments contribute positively to society and align with your impact objectives.

Managing Reporting and KPIs

Effective reporting keeps stakeholders informed and engaged. Start by defining key performance indicators (KPIs) for each investment. These KPIs should align with your overall goals and provide a clear measure of success.

Establish a regular reporting schedule. Consistent updates keep everyone informed and allow for timely adjustments. Use clear, concise reports that highlight critical information.

Utilize technology to streamline reporting. Automated systems can simplify data collection and analysis, allowing for more efficient reporting processes.

Operational Execution and Support

For sustained success, operational execution and support are vital. This section will explore structuring special purpose vehicles (SPVs), curating deal flow, and building a syndication platform.

SPV Structuring and Legal Considerations

Special Purpose Vehicles (SPVs) are essential for managing investments efficiently. They provide flexibility and limit liability. Start by determining the structure that suits your needs: corporation, partnership, or trust.

Consult legal experts to ensure compliance with regulations. Each structure has unique legal implications, and professional guidance is vital for navigating complexities.

Clearly outline the roles and responsibilities within the SPV. This ensures smooth operations and helps manage potential conflicts. With a well-structured SPV, you can handle investments effectively and mitigate risks.

Curation of Deal Flow and Monitoring

Curating a robust deal flow is critical for discovering high-impact opportunities. Identify key sources for potential investments, such as industry networks or venture partners.

Develop criteria for evaluating deals. This includes strategic fit, financial health, and growth potential. Consistent evaluation ensures only the best opportunities are pursued.

Implement a monitoring system for ongoing assessment. Regular reviews of portfolio performance help in making informed decisions and adjusting strategies as needed.

Building a Syndication Platform

A syndication platform enables collaboration with other investors. It broadens your investment reach and shares risks. Begin by selecting a platform that fits your needs, whether it's online or through a network.

Establish relationships with co-investors. Building a strong network enhances collaboration and access to deals. Ensure clear communication and alignment of interests among all parties.

Regularly assess and optimize the platform. Technology and market conditions evolve, and your platform should adapt accordingly to remain effective.

In conclusion, creating a disciplined co-investment framework requires careful planning and execution. By defining your mandate, structuring governance, and ensuring ongoing alignment, you can achieve your investment goals with confidence.